Binding	O
of	O
c-Rel	B-protein
to	O
STAT5	B-DNA
target	I-DNA
sequences	I-DNA
in	O
HTLV-I-transformed	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

The	O
type	O
I	O
human	O
T-cell	O
leukemia	O
virus	O
(	O
HTLV-I	O
)	O
induces	O
abnormal	O
growth	O
and	O
subsequent	O
transformation	O
of	O
T	B-cell_type
cells	I-cell_type
,	O
which	O
is	O
associated	O
with	O
the	O
development	O
of	O
an	O
acute	O
T-cell	O
malignancy	O
termed	O
adult	O
T-cell	O
leukemia	O
.	O

A	O
characteristic	O
of	O
HTLV-I-transformed	B-cell_type
T	I-cell_type
cells	I-cell_type
is	O
the	O
constitutive	O
nuclear	O
expression	O
of	O
NF-kappaB/Rel	B-protein
family	I-protein
of	O
transcription	O
factors	O
,	O
which	O
appears	O
to	O
be	O
essential	O
for	O
the	O
growth	O
of	O
these	O
transformed	B-cell_type
cells	I-cell_type
.	O

Although	O
NF-kappaB/Rel	B-protein
factors	I-protein
are	O
known	O
to	O
induce	O
the	O
expression	O
of	O
T-cell	B-protein
growth	I-protein
factor	I-protein
interleukin	I-protein
(	I-protein
IL	I-protein
)	I-protein
-2	I-protein
,	O
it	O
is	O
unclear	O
how	O
they	O
participate	O
in	O
the	O
IL-2	B-protein
-independent	O
growth	O
of	O
HTLV-I-transformed	B-cell_line
cells	I-cell_line
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
certain	O
NF-kappaB/Rel	B-protein
members	I-protein
,	O
predominantly	O
c-Rel	B-protein
,	O
interact	O
with	O
enhancer	O
sequences	O
for	O
STAT5	B-protein
,	O
a	O
key	O
transcription	O
factor	O
mediating	O
IL-2	B-protein
-induced	O
T-cell	O
proliferation	O
.	O

Reporter	O
gene	O
assays	O
reveal	O
that	O
the	O
binding	O
of	O
c-Rel	B-protein
to	O
the	O
STAT5	B-protein
site	O
present	O
in	O
the	O
Fc	B-DNA
gammaR1	I-DNA
gene	I-DNA
leads	O
to	O
potent	O
transactivation	O
of	O
this	O
enhancer	O
.	O

Binding	O
of	O
c-Rel	B-protein
to	O
the	O
Fc	B-DNA
gammaR1	I-DNA
STAT	I-DNA
site	I-DNA
also	O
occurs	O
in	O
human	O
peripheral	B-cell_type
blood	I-cell_type
T	I-cell_type
cells	I-cell_type
immortalized	O
with	O
HTLV-I	O
in	O
vitro	O
and	O
is	O
correlated	O
with	O
enhanced	O
levels	O
of	O
proliferation	O
of	O
these	O
cells	O
.	O

These	O
results	O
raise	O
the	O
possibility	O
that	O
NF-kappaB/Rel	B-protein
may	O
participate	O
in	O
the	O
growth	O
control	O
of	O
HTLV-I-transformed	B-cell_line
T	I-cell_line
cells	I-cell_line
by	O
regulating	O
genes	O
driven	O
by	O
both	O
kappaB	B-DNA
and	O
certain	O
STAT	B-DNA
enhancers	I-DNA
.	O

Oncogene	NULL
(	NULL
1999	NULL
)	NULL
18	NULL
,	NULL
1401-1409	NULL
Â©	NULL
1999	NULL
Stockton	NULL
Press	NULL
All	NULL
rights	NULL
reserved	NULL
0950-9232/99	NULL
$	NULL
12.00	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

stockton-press.co.uk/onc	NULL
Binding	NULL
of	NULL
c-Rel	NULL
to	NULL
STATS	NULL
target	NULL
sequences	NULL
in	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
Shao-Cong	NULL
Sun	NULL
'	NULL
,	NULL
Sanjay	NULL
B	NULL
Maggirwar	NULL
'	NULL
,	NULL
Edward	NULL
W	NULL
Harhaj	NULL
'	NULL
and	NULL
Mark	NULL
Uhlik	NULL
'	NULL
'Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Pennsylvania	NULL
State	NULL
University	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Hershey	NULL
Medical	NULL
Center	NULL
,	NULL
PO	NULL
Box	NULL
850	NULL
,	NULL
Hershey	NULL
,	NULL
Pennsylvania	NULL
17033	NULL
,	NULL
USA	NULL
The	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
induces	NULL
abnormal	NULL
growth	NULL
and	NULL
subsequent	NULL
transformation	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
development	NULL
of	NULL
an	NULL
acute	NULL
T-cell	NULL
malignancy	NULL
termed	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

A	NULL
characteristic	NULL
of	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
is	NULL
the	NULL
constitutive	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-xB/Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
appears	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
the	NULL
growth	NULL
of	NULL
these	NULL
transformed	NULL
cells	NULL
.	NULL

Although	NULL
NF-xB/	NULL
Rel	NULL
factors	NULL
are	NULL
known	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
T-cell	NULL
growth	NULL
factor	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-2	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
how	NULL
they	NULL
participate	NULL
in	NULL
the	NULL
IL-2-independent	NULL
growth	NULL
of	NULL
HTLV-I-transformed	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
show	NULL
that	NULL
certain	NULL
NF-xB/Rel	NULL
members	NULL
,	NULL
predominantly	NULL
c-Rel	NULL
,	NULL
interact	NULL
with	NULL
enhancer	NULL
sequences	NULL
for	NULL
STATS	NULL
,	NULL
a	NULL
key	NULL
transcription	NULL
factor	NULL
mediating	NULL
IL-2-induced	NULL
T-cell	NULL
proliferation	NULL
.	NULL

Reporter	NULL
gene	NULL
assays	NULL
reveal	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
c-Rel	NULL
to	NULL
the	NULL
STATS	NULL
site	NULL
present	NULL
in	NULL
the	NULL
FcyR1	NULL
gene	NULL
leads	NULL
to	NULL
potent	NULL
transactivation	NULL
of	NULL
this	NULL
enhancer	NULL
.	NULL

Binding	NULL
of	NULL
c-Rel	NULL
to	NULL
the	NULL
FcyR1	NULL
STAT	NULL
site	NULL
also	NULL
occurs	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
immortalized	NULL
with	NULL
HTLV-I	NULL
in	NULL
vitro	NULL
and	NULL
is	NULL
correlated	NULL
with	NULL
enhanced	NULL
levels	NULL
of	NULL
proliferation	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
NF-xB/Rel	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
growth	NULL
control	NULL
of	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
by	NULL
regulating	NULL
genes	NULL
driven	NULL
by	NULL
both	NULL
xB	NULL
and	NULL
certain	NULL
STAT	NULL
enhancers	NULL
.	NULL

Keywords	NULL
:	NULL
HTLV-I	NULL
;	NULL
c-Rel	NULL
;	NULL
STAT	NULL
;	NULL
T-cell	NULL
transforma-tion	NULL
;	NULL
NF-xB	NULL
Introduction	NULL
The	NULL
proliferation	NULL
of	NULL
normal	NULL
T	NULL
cells	NULL
is	NULL
tightly	NULL
controlled	NULL
by	NULL
various	NULL
cytokines	NULL
,	NULL
most	NULL
importantly	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
,	NULL
which	NULL
is	NULL
produced	NULL
as	NULL
a	NULL
result	NULL
of	NULL
antigen-mediated	NULL
activation	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
(	NULL
Schwartz	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
cytokines	NULL
to	NULL
their	NULL
cell	NULL
surface	NULL
receptors	NULL
triggers	NULL
a	NULL
cascade	NULL
of	NULL
signal	NULL
transduc-tion	NULL
events	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
various	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
(	NULL
PTK	NULL
)	NULL
,	NULL
including	NULL
members	NULL
of	NULL
the	NULL
Janus	NULL
kinase	NULL
(	NULL
JAK	NULL
)	NULL
family	NULL
(	NULL
Johnston	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Witthuhn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
JAKs	NULL
then	NULL
phosphorylate	NULL
and	NULL
induce	NULL
the	NULL
dimerization	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
a	NULL
family	NULL
of	NULL
enhancer	NULL
binding	NULL
proteins	NULL
termed	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
(	NULL
Darnell	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Ihle	NULL
,	NULL
1996	NULL
;	NULL
Schindler	NULL
and	NULL
Correspondence	NULL
:	NULL
S-C	NULL
Sun	NULL
*Current	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Rochester	NULL
Medical	NULL
Center	NULL
,	NULL
575	NULL
Elmwood	NULL
Avenue	NULL
,	NULL
Box	NULL
672	NULL
,	NULL
Rochester	NULL
,	NULL
NY14642	NULL
,	NULL
USA	NULL
Received	NULL
14	NULL
May	NULL
1998	NULL
;	NULL
revised	NULL
16	NULL
September	NULL
1998	NULL
;	NULL
accepted	NULL
16	NULL
September	NULL
1998	NULL
Darnell	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
STAT	NULL
factors	NULL
function	NULL
by	NULL
binding	NULL
to	NULL
an	NULL
enhancer	NULL
element	NULL
termed	NULL
interferon	NULL
gamma-activated	NULL
site	NULL
(	NULL
GAS	NULL
)	NULL
that	NULL
is	NULL
present	NULL
in	NULL
the	NULL
promoter	NULL
regions	NULL
of	NULL
various	NULL
cytokine-regulated	NULL
genes	NULL
(	NULL
Darnell	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Ihle	NULL
,	NULL
1996	NULL
;	NULL
Schindler	NULL
and	NULL
Darnell	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
distinct	NULL
biological	NULL
effects	NULL
of	NULL
different	NULL
cytokines	NULL
appear	NULL
to	NULL
be	NULL
mediated	NULL
,	NULL
at	NULL
least	NULL
partially	NULL
,	NULL
by	NULL
the	NULL
activation	NULL
of	NULL
specific	NULL
STAT	NULL
factors	NULL
(	NULL
Ihle	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

Different	NULL
STAT	NULL
factors	NULL
in	NULL
turn	NULL
recognize	NULL
distinct	NULL
GAS	NULL
sequences	NULL
and	NULL
regulate	NULL
different	NULL
target	NULL
genes	NULL
(	NULL
Ihle	NULL
,	NULL
1996	NULL
;	NULL
Lin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
O'Shea	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
lymphoid	NULL
cells	NULL
,	NULL
IL-2	NULL
is	NULL
known	NULL
to	NULL
induce	NULL
STATS	NULL
as	NULL
well	NULL
as	NULL
STAT3	NULL
(	NULL
Fujii	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Johnston	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
,	NULL
1995	NULL
;	NULL
Witthuhn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

While	NULL
the	NULL
proliferation	NULL
of	NULL
normal	NULL
T	NULL
cells	NULL
largely	NULL
relies	NULL
on	NULL
the	NULL
action	NULL
of	NULL
IL-2	NULL
,	NULL
under	NULL
certain	NULL
situations	NULL
T	NULL
cells	NULL
may	NULL
undergo	NULL
proliferation	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
.	NULL

One	NULL
example	NULL
is	NULL
seen	NULL
with	NULL
T	NULL
cells	NULL
infected	NULL
with	NULL
the	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV-I	NULL
)	NULL
,	NULL
the	NULL
etiologic	NULL
agent	NULL
of	NULL
an	NULL
acute	NULL
and	NULL
often	NULL
fatal	NULL
T	NULL
cell	NULL
malignancy	NULL
termed	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
(	NULL
ATL	NULL
)	NULL
(	NULL
Poiesz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1980	NULL
;	NULL
Yoshida	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1982	NULL
)	NULL
.	NULL

HTLV-I	NULL
preferentially	NULL
infects	NULL
CD4*T	NULL
cells	NULL
,	NULL
enabling	NULL
them	NULL
to	NULL
undergo	NULL
spontaneous	NULL
proliferation	NULL
in	NULL
vitro	NULL
,	NULL
even	NULL
though	NULL
these	NULL
cells	NULL
rarely	NULL
produce	NULL
IL-2	NULL
(	NULL
HÃ©ollsberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Precisely	NULL
how	NULL
HTLV-I	NULL
induces	NULL
the	NULL
IL-2-independent	NULL
proliferation	NULL
of	NULL
T	NULL
cells	NULL
remains	NULL
elusive	NULL
.	NULL

However	NULL
,	NULL
emerging	NULL
evidence	NULL
suggests	NULL
that	NULL
deregulation	NULL
of	NULL
various	NULL
cellular	NULL
transcription	NULL
factors	NULL
by	NULL
the	NULL
virus	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
(	NULL
Ressler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
HTLV-I	NULL
encodes	NULL
a	NULL
transactivator	NULL
protein	NULL
termed	NULL
Tax	NULL
,	NULL
which	NULL
activates	NULL
or	NULL
enhances	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
members	NULL
from	NULL
the	NULL
NF-xB/Rel	NULL
families	NULL
(	NULL
Smith	NULL
and	NULL
Greene	NULL
,	NULL
1991	NULL
;	NULL
Yoshida	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-xB/Rel	NULL
appears	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
the	NULL
growth	NULL
of	NULL
both	NULL
Tax-transformed	NULL
murine	NULL
fibroblasts	NULL
and	NULL
HTLV-I-transformed	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
Akagi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Kitajima	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Yamaoka	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
NF-xB/Rel	NULL
family	NULL
is	NULL
composed	NULL
of	NULL
at	NULL
least	NULL
five	NULL
members	NULL
,	NULL
including	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
RelA	NULL
,	NULL
RelB	NULL
and	NULL
the	NULL
proto-oncoprotein	NULL
c-Rel	NULL
(	NULL
reviewed	NULL
in	NULL
Gilmore	NULL
,	NULL
1990	NULL
;	NULL
Siebenlist	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
normal	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
in	NULL
many	NULL
other	NULL
cell	NULL
types	NULL
,	NULL
the	NULL
biological	NULL
activity	NULL
of	NULL
NF-xB/Rel	NULL
is	NULL
tightly	NULL
regulated	NULL
through	NULL
its	NULL
cytoplasmic	NULL
retention	NULL
by	NULL
specific	NULL
inhibitory	NULL
proteins	NULL
termed	NULL
IxB	NULL
(	NULL
Beg	NULL
and	NULL
Baldwin	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
NF-xB/Rel	NULL
by	NULL
immuno-logical	NULL
and	NULL
mitogenic	NULL
signals	NULL
involves	NULL
the	NULL
induction	NULL
of	NULL
IxB	NULL
phosphorylation	NULL
and	NULL
proteolysis	NULL
,	NULL
allowing	NULL
the	NULL
released	NULL
NF-xB/Rel	NULL
factors	NULL
to	NULL
enter	NULL
the	NULL
nucleus	NULL
(	NULL
Beg	NULL
and	NULL
Baldwin	NULL
,	NULL
1993	NULL
;	NULL
Stancovski	NULL
and	NULL
Baltimore	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
Tax	NULL
can	NULL
induce	NULL
the	NULL
persistent	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
the	NULL
IxB	NULL
molecules	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
constitutive	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-xB/Rel	NULL
Functional	NULL
binding	NULL
of	NULL
c-Rel	NULL
to	NULL
STATS	NULL
target	NULL
sequences	NULL
SC	NULL
Sun	NULL
et	NULL
al	NULL
1402	NULL
(	NULL
Brockman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Good	NULL
and	NULL
Sun	NULL
,	NULL
1996	NULL
;	NULL
Kanno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Lacoste	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
McKinsey	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Among	NULL
the	NULL
NF-xB/Rel	NULL
factors	NULL
,	NULL
c-Rel	NULL
is	NULL
a	NULL
predominant	NULL
form	NULL
in	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
(	NULL
Li	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Although	NULL
c-Rel	NULL
is	NULL
clearly	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
genes	NULL
(	NULL
Kontgen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
how	NULL
the	NULL
Rel	NULL
protein	NULL
participates	NULL
in	NULL
the	NULL
growth	NULL
control	NULL
of	NULL
HTLV-I-transformed	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
NF-xB/Rel	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
certain	NULL
STAT	NULL
factors	NULL
are	NULL
constitutively	NULL
activated	NULL
in	NULL
some	NULL
HTLV-I-transformed	NULL
T-cell	NULL
lines	NULL
(	NULL
Migone	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Mulloy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Takemoto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
deregulated	NULL
expression	NULL
of	NULL
STAT	NULL
target	NULL
genes	NULL
may	NULL
contribute	NULL
to	NULL
HTLV-I-induced	NULL
IL-2-independent	NULL
T-cell	NULL
proliferation	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
show	NULL
that	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
Â«	NULL
xB/	NULL
Rel	NULL
family	NULL
,	NULL
especially	NULL
c-Rel	NULL
,	NULL
can	NULL
also	NULL
bind	NULL
to	NULL
the	NULL
target	NULL
DNA	NULL
sequence	NULL
of	NULL
STATs	NULL
and	NULL
transactivate	NULL
STAT-specific	NULL
reporter	NULL
genes	NULL
.	NULL

These	NULL
findings	NULL
raise	NULL
the	NULL
intriguing	NULL
possibility	NULL
that	NULL
NF-xB/Rel	NULL
factors	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
certain	NULL
STAT	NULL
target	NULL
genes	NULL
.	NULL

Results	NULL
Constitutive	NULL
activation	NULL
of	NULL
GAS-binding	NULL
nuclear	NULL
factors	NULL
in	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
To	NULL
investigate	NULL
whether	NULL
constitutive	NULL
activation	NULL
of	NULL
STAT	NULL
factors	NULL
is	NULL
a	NULL
common	NULL
feature	NULL
for	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
,	NULL
EMSA	NULL
was	NULL
performed	NULL
to	NULL
examine	NULL
the	NULL
FoyR1	NULL
GAS-binding	NULL
activity	NULL
in	NULL
a	NULL
number	NULL
of	NULL
IL-2-independent	NULL
HTLV-I-transformed	NULL
human	NULL
T-cell	NULL
lines	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1	NULL
,	NULL
no	NULL
significant	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
from	NULL
the	NULL
extracts	NULL
of	NULL
normal	NULL
resting	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
the	NULL
HTLV-I-negative	NULL
Jurkat	NULL
leukemic	NULL
T	NULL
cells	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
strong	NULL
GAS-binding	NULL
activity	NULL
was	NULL
detected	NULL
(	NULL
C1	NULL
and	NULL
C2	NULL
)	NULL
C14	NULL
C24	NULL
Â»	NULL
NS	NULL
44	NULL
>	NULL
{	NULL
bl	NULL
41	NULL
}	NULL
1660ng	NULL
Figure	NULL
1	NULL
Constitutive	NULL
GAS-binding	NULL
activity	NULL
in	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
IL-2-starved	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
(	NULL
PBL	NULL
)	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
or	NULL
the	NULL
indicated	NULL
HTLV-I-transformed	NULL
T-cell	NULL
lines	NULL
.	NULL

STAT-like	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
by	NULL
EMSA	NULL
using	NULL
a	NULL
*Â°P-radiolabelled	NULL
probe	NULL
covering	NULL
the	NULL
FeyR1	NULL
GAS	NULL
element	NULL
.	NULL

Two	NULL
specific	NULL
complexes	NULL
(	NULL
Cl	NULL
and	NULL
C2	NULL
)	NULL
were	NULL
detected	NULL
.	NULL

NS	NULL
indicates	NULL
a	NULL
non-specific	NULL
band	NULL
from	NULL
each	NULL
of	NULL
the	NULL
HTLV-I-transformed	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
MT2	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
C8166	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
HUTI1O2	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
and	NULL
SLB-1	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

We	NULL
then	NULL
analysed	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
GAS-binding	NULL
protein	NULL
complexes	NULL
using	NULL
antibody	NULL
'supershift	NULL
'	NULL
assays	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
(	NULL
Migone	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
the	NULL
GAS-binding	NULL
factors	NULL
from	NULL
the	NULL
MT-2	NULL
cells	NULL
included	NULL
both	NULL
STATS	NULL
and	NULL
STAT3	NULL
,	NULL
since	NULL
one	NULL
of	NULL
the	NULL
complexes	NULL
(	NULL
Cl	NULL
)	NULL
was	NULL
supershifted	NULL
by	NULL
antisera	NULL
specific	NULL
for	NULL
human	NULL
STATS	NULL
(	NULL
Figure	NULL
2	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
STAT3	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
but	NULL
not	NULL
by	NULL
a	NULL
preimmune	NULL
serum	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Using	NULL
the	NULL
same	NULL
strategy	NULL
,	NULL
STAT5	NULL
,	NULL
although	NULL
not	NULL
STAT3	NULL
,	NULL
was	NULL
also	NULL
detected	NULL
from	NULL
HUTIO2	NULL
cells	NULL
(	NULL
lanes	NULL
5-7	NULL
)	NULL
.	NULL

Unexpectedly	NULL
,	NULL
however	NULL
,	NULL
neither	NULL
anti-STATS5	NULL
nor	NULL
anti-STAT3	NULL
immunoreacted	NULL
with	NULL
the	NULL
C2	NULL
complex	NULL
detected	NULL
from	NULL
C8166	NULL
(	NULL
lanes	NULL
8-10	NULL
)	NULL
,	NULL
SLB-1	NULL
(	NULL
11-13	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
MT-2	NULL
and	NULL
HUT102	NULL
cells	NULL
(	NULL
lanes	NULL
1-7	NULL
,	NULL
C2	NULL
)	NULL
.	NULL

MT-2	NULL
HUT102	NULL
I1	NULL
2	NULL
3	NULL
4	NULL
!	NULL

5	NULL
6	NULL
7|	NULL
ls	NULL
#	NULL
m	NULL
Â»	NULL
C1-m	NULL
Â»	NULL
ca	NULL
Â»	NULL
Ill	NULL
WHL	NULL
NS	NULL
-m	NULL
2.5	NULL
%	NULL
\\\	NULL
'\\\	NULL
\\\	NULL
C8166	NULL
SLB-1	NULL
9	NULL
10	NULL
â	NULL
51	NULL
12	NULL
13	NULL
'	NULL
Antisera	NULL
â	NULL
o	NULL
â	NULL
i	NULL
â	NULL
q	NULL
,	NULL
0,1	NULL
I	NULL
â	NULL
p	NULL
,	NULL
I	NULL
)	NULL
,	NULL
91	NULL
,	NULL
``	NULL
a	NULL
.	NULL

``	NULL
o	NULL
,	NULL
``	NULL
oC	NULL
``	NULL
9	NULL
,	NULL
``	NULL
s	NULL
Col	NULL
?	NULL

~	NULL
CK	NULL
mie	NULL
``	NULL
ofise	NULL
``	NULL
57	NULL
5	NULL
)	NULL
4	NULL
)	NULL
.	NULL

29	NULL
o	NULL
4731	NULL
}	NULL
41,4	NULL
)	NULL
.	NULL

473433	NULL
b	NULL
C8166	NULL
SLB-1	NULL
11	NULL
1213	NULL
I	NULL
1	NULL
8	NULL
9	NULL
10	NULL
C2	NULL
-m	NULL
Â»	NULL
NS	NULL
-1m	NULL
>	NULL
Antisera	NULL
-	NULL
%	NULL
%	NULL
0	NULL
``	NULL
Â¢	NULL
Pa	NULL
C.	NULL
(	NULL
19	NULL
O	NULL
â	NULL
Sjï¬s	NULL
}	NULL
Trip	NULL
yl	NULL
Â»	NULL
Figure	NULL
2	NULL
Involvement	NULL
of	NULL
both	NULL
STATs	NULL
and	NULL
non-STAT	NULL
factors	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
GAS-binding	NULL
complexes	NULL
in	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
a	NULL
)	NULL
EMSA	NULL
was	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
of	NULL
the	NULL
indicated	NULL
cell	NULL
lines	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
none	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
a	NULL
preimmune	NULL
or	NULL
specific	NULL
anti-STAT	NULL
immune	NULL
sera	NULL
.	NULL

The	NULL
supershifted	NULL
complexes	NULL
are	NULL
indicated	NULL
by	NULL
an	NULL
arrowhead	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Lack	NULL
of	NULL
STAT	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
C8166	NULL
and	NULL
SLB-1	NULL
cells	NULL
EMSA	NULL
and	NULL
supershift	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
in	NULL
lanes	NULL
8-13	NULL
of	NULL
a	NULL
,	NULL
but	NULL
a	NULL
longer	NULL
time	NULL
of	NULL
autoradiography	NULL
was	NULL
performed	NULL
fila	NULL
***	NULL
TC	NULL
``	NULL
o-	NULL
>	NULL
-	NULL
edad	NULL
atts	NULL
S2	NULL
aG	NULL
59	NULL
898g	NULL
.	NULL

84,57	NULL
Antisera	NULL
%	NULL
p	NULL
606906006	NULL
?	NULL

005	NULL
,	NULL
004	NULL
â	NULL
b	NULL
,	NULL
I	NULL
?	NULL

$	NULL
006	NULL
?	NULL

&	NULL
04	NULL
â	NULL
9	NULL
Q0	NULL
Â«	NULL
5	NULL
â	NULL
u	NULL
?	NULL

b	NULL
MT-2	NULL
SLB-1	NULL
HUT102	NULL
1	NULL
2	NULL
3	NULL
4a	NULL
500	NULL
6	NULL
7s	NULL
919	NULL
'	NULL
I1.11I2	NULL
'	NULL
I	NULL
\\\\	NULL
ANR	NULL
K	NULL
\a	NULL
``	NULL
``	NULL
o	NULL
$	NULL
0660b	NULL
06	NULL
Q	NULL
``	NULL
,	NULL
06	NULL
00	NULL
~	NULL
0Â°	NULL
lb	NULL
,	NULL
00	NULL
6	NULL
o.	NULL
b	NULL
``	NULL
c	NULL
gt	NULL
,	NULL
'	NULL
C	NULL
HT-2	NULL
(	NULL
IL-2	NULL
)	NULL
1	NULL
2	NULL
3	NULL
4	NULL
$	NULL
00	NULL
m	NULL
tms	NULL
6\	NULL
&	NULL
Â§\	NULL
&	NULL
;	NULL
00	NULL
4	NULL
)	NULL
.	NULL

â	NULL
1	NULL
PX	NULL
Figure	NULL
3	NULL
The	NULL
proto-oncoprotein	NULL
c-Rel	NULL
is	NULL
a	NULL
predominant	NULL
GAS-binding	NULL
factor	NULL
in	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Antibody	NULL
supershift	NULL
analyses	NULL
of	NULL
the	NULL
GAS-binding	NULL
complex	NULL
detected	NULL
from	NULL
C8166	NULL
cells	NULL
EMSA	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
none	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
preimmune	NULL
or	NULL
specific	NULL
antisera	NULL
.	NULL

The	NULL
arrowhead	NULL
indicates	NULL
a	NULL
complex	NULL
migrating	NULL
more	NULL
slowly	NULL
than	NULL
C2	NULL
(	NULL
but	NULL
faster	NULL
than	NULL
C1	NULL
)	NULL
.	NULL

Both	NULL
this	NULL
faint	NULL
complex	NULL
and	NULL
C2	NULL
weakly	NULL
immunoreacted	NULL
with	NULL
antisera	NULL
for	NULL
p50	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
and	NULL
p52	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
Functional	NULL
binding	NULL
of	NULL
c-Rel	NULL
to	NULL
STATS	NULL
target	NULL
sequences	NULL
SC	NULL
Sun	NULL
et	NULL
al	NULL
The	NULL
c-Rel	NULL
proto-oncoprotein	NULL
is	NULL
a	NULL
predominant	NULL
GAS-binding	NULL
factor	NULL
in	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
To	NULL
examine	NULL
the	NULL
molecular	NULL
nature	NULL
of	NULL
the	NULL
C2	NULL
complex	NULL
,	NULL
supershift	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
antibodies	NULL
specific	NULL
for	NULL
various	NULL
transcription	NULL
factors	NULL
known	NULL
to	NULL
be	NULL
activated	NULL
in	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Antisera	NULL
for	NULL
the	NULL
p50	NULL
and	NULL
p52	NULL
subunits	NULL
of	NULL
NF-xB/Rel	NULL
partially	NULL
supershifted	NULL
the	NULL
C2	NULL
complex	NULL
detected	NULL
in	NULL
C8166	NULL
cells	NULL
(	NULL
Figure	NULL
3a	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
while	NULL
no	NULL
immunoreactivity	NULL
was	NULL
observed	NULL
with	NULL
a	NULL
preimmune	NULL
serum	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
or	NULL
antisera	NULL
for	NULL
RelA	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
STAT3	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
STATS	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Remarkably	NULL
,	NULL
the	NULL
entire	NULL
GAS-binding	NULL
complex	NULL
was	NULL
supershifted	NULL
by	NULL
a	NULL
peptide-specific	NULL
antibody	NULL
for	NULL
c-Rel	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

We	NULL
noticed	NULL
that	NULL
a	NULL
weak	NULL
and	NULL
more	NULL
slowly	NULL
migrating	NULL
complex	NULL
could	NULL
be	NULL
occasionally	NULL
detected	NULL
in	NULL
our	NULL
EMSA	NULL
(	NULL
Figure	NULL
3a	NULL
,	NULL
arrowhead	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
,	NULL
which	NULL
migrated	NULL
slightly	NULL
faster	NULL
than	NULL
the	NULL
STATS-containing	NULL
C1	NULL
complex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
had	NULL
no	NULL
immunoreactivity	NULL
with	NULL
the	NULL
antibodies	NULL
for	NULL
STATS5	NULL
(	NULL
Figure	NULL
3a	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
STAT3	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
but	NULL
was	NULL
completely	NULL
supershifted	NULL
by	NULL
the	NULL
anti-c-Rel	NULL
antibody	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Similar	NULL
supershift	NULL
assays	NULL
demonstrated	NULL
that	NULL
the	NULL
C2	NULL
complex	NULL
detected	NULL
in	NULL
the	NULL
other	NULL
three	NULL
HTLV-I-transformed	NULL
cell	NULL
lines	NULL
was	NULL
also	NULL
supershifted	NULL
by	NULL
the	NULL
anti-c-Rel	NULL
antibody	NULL
(	NULL
Figure	NULL
3b	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
9	NULL
and	NULL
12	NULL
)	NULL
.	NULL

The	NULL
supershift	NULL
generated	NULL
by	NULL
the	NULL
anti-c-Rel	NULL
antibody	NULL
was	NULL
specific	NULL
since	NULL
this	NULL
antibody	NULL
failed	NULL
to	NULL
supershift	NULL
the	NULL
STATS	NULL
complex	NULL
detected	NULL
from	NULL
the	NULL
IL-2-stimulated	NULL
HT-2	NULL
cells	NULL
(	NULL
Figure	NULL
3Â¢c	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
c-Rel	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
major	NULL
GAS-binding	NULL
factor	NULL
in	NULL
all	NULL
the	NULL
four	NULL
HTLV-I-transformed	NULL
T-cell	NULL
lines	NULL
analysed	NULL
.	NULL

c-Rel	NULL
preferentially	NULL
binds	NULL
to	NULL
STAT5-specific	NULL
GAS-related	NULL
sequences	NULL
We	NULL
then	NULL
performed	NULL
oligonucleotide	NULL
competition	NULL
assays	NULL
to	NULL
compare	NULL
the	NULL
DNA	NULL
binding	NULL
specificity	NULL
of	NULL
c-Rel	NULL
and	NULL
STAT	NULL
.	NULL

For	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
used	NULL
a	NULL
nuclear	NULL
extract	NULL
isolated	NULL
from	NULL
the	NULL
MT-2	NULL
cells	NULL
since	NULL
it	NULL
contained	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
both	NULL
STATS	NULL
and	NULL
c-Rel	NULL
(	NULL
see	NULL
Figures	NULL
2	NULL
and	NULL
3b	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
STATS	NULL
to	NULL
the	NULL
``	NULL
P-labeled	NULL
FcyRI	NULL
GAS	NULL
probe	NULL
was	NULL
completely	NULL
abrogated	NULL
when	NULL
excess	NULL
amounts	NULL
(	NULL
50-	NULL
or	NULL
100-fold	NULL
molar	NULL
excess	NULL
)	NULL
of	NULL
the	NULL
same	NULL
probe	NULL
was	NULL
added	NULL
to	NULL
the	NULL
EMSA	NULL
reaction	NULL
(	NULL
Figure	NULL
4b	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
,	NULL
upper	NULL
band	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
formation	NULL
of	NULL
the	NULL
c-Rel	NULL
complex	NULL
was	NULL
also	NULL
blocked	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
,	NULL
lower	NULL
band	NULL
)	NULL
.	NULL

The	NULL
efficiency	NULL
of	NULL
competition	NULL
for	NULL
the	NULL
STATS-	NULL
and	NULL
c-Rel-DNA	NULL
complexes	NULL
was	NULL
similar	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
two	NULL
factors	NULL
have	NULL
similar	NULL
binding	NULL
affinity	NULL
to	NULL
the	NULL
FcoyRI1	NULL
GAS	NULL
sequence	NULL
.	NULL

However	NULL
,	NULL
STATS	NULL
and	NULL
c-Rel	NULL
appeared	NULL
to	NULL
have	NULL
markedly	NULL
different	NULL
binding	NULL
affinity	NULL
to	NULL
the	NULL
IL-2R	NULL
Â«	NULL
xB	NULL
site	NULL
,	NULL
as	NULL
this	NULL
probe	NULL
selectively	NULL
competed	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
c-Rel/GAS	NULL
complex	NULL
but	NULL
had	NULL
no	NULL
obvious	NULL
effect	NULL
on	NULL
formation	NULL
of	NULL
the	NULL
STAT5S/GAS	NULL
and	NULL
were	NULL
completely	NULL
supershifted	NULL
by	NULL
the	NULL
anti-c-Rel	NULL
antiserum	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Antibody	NULL
supershift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
a	NULL
using	NULL
nuclear	NULL
extracts	NULL
of	NULL
the	NULL
indicated	NULL
cells	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Antibody	NULL
supershift	NULL
analyses	NULL
of	NULL
the	NULL
GAS-binding	NULL
complexes	NULL
from	NULL
IL-2-stimulated	NULL
HT-2	NULL
cells	NULL
1403	NULL
Functional	NULL
binding	NULL
of	NULL
c-Rel	NULL
to	NULL
STATS	NULL
target	NULL
sequences	NULL
SC	NULL
Sun	NULL
et	NULL
al	NULL
1404	NULL
a	NULL
FeyR1	NULL
ATGTATTTCCCAGAAAAGG	NULL
FcyR1	NULL
Mut	NULL
ATGTATTTGGGAGAAAAGG	NULL
IRF-1	NULL
CCTGATTTCCCCGAAATGATGAGC	NULL
APRE	NULL
TAGGAATTCCCAGAAGGATC	NULL
LY6/E	NULL
CATGTTATGCATATTCCTGTAAGT	NULL
Is	NULL
GTCAACTTCCCAAGAACAGAA	NULL
SIE	NULL
GTCGACAGTTCCCGTCAATC	NULL
ISRE	NULL
TTCGGTTTCCCTTTCCCGATC	NULL
IL-2Ra	NULL
xB	NULL
AGGGAGATTCCCCTGC	NULL
b	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
aa	NULL
a	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
1	NULL
's	NULL
1	NULL
?	NULL

STAT5	NULL
-t-c-Rel-m	NULL
NS	NULL
im	NULL
ma	NULL
8	NULL
%	NULL
Â§	NULL
8	NULL
%	NULL
aa	NULL
2	NULL
aa	NULL
8	NULL
8a	NULL
8a	NULL
S	NULL
85	NULL
Sa	NULL
S3	NULL
Sa	NULL
y	NULL
Sa	NULL
R	NULL
\	NULL
14	NULL
%	NULL
4	NULL
%	NULL
zgugqbqpÃ©	NULL
mï¬	NULL
â	NULL
oo	NULL
â	NULL
bl	NULL
â	NULL
bmo	NULL
â	NULL
ao	NULL
FcyR1	NULL
IRF-1	NULL
APRE	NULL
Ly6/E	NULL
Is	NULL
-	NULL
SIE	NULL
ISRE	NULL
xB	NULL
ForR1	NULL
WT	NULL
Mut	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
th	NULL
3	NULL
%	NULL
c-Rel	NULL
ians	NULL
~	NULL
Ch	NULL
ans	NULL
A	NULL
Sa	NULL
S	NULL
,	NULL
N	NULL
,	NULL
4	NULL
%	NULL
E39	NULL
%	NULL
â	NULL
%	NULL
â	NULL
?	NULL

s	NULL
â	NULL
Â°	NULL
â	NULL
o\	NULL
â	NULL
q	NULL
,	NULL
FoyR1	NULL
_	NULL
IL-2Ra	NULL
GAS	NULL
xB	NULL
NS	NULL
im	NULL
Figure	NULL
4	NULL
Competition	NULL
assays	NULL
showing	NULL
the	NULL
DNA	NULL
binding	NULL
specificity	NULL
of	NULL
c-Rel	NULL
and	NULL
STATS	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Sequence	NULL
of	NULL
the	NULL
oligonucleo-tides	NULL
used	NULL
in	NULL
the	NULL
competition	NULL
assays	NULL
.	NULL

Only	NULL
the	NULL
sense	NULL
strand	NULL
sequences	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
b	NULL
)	NULL
EMSA	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
radiolabeled	NULL
wildtype	NULL
FcyR1	NULL
GAS	NULL
probe	NULL
and	NULL
MT-2	NULL
nuclear	NULL
extract	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
amounts	NULL
(	NULL
fold	NULL
molar	NULL
excess	NULL
)	NULL
of	NULL
various	NULL
unlabeled	NULL
oligonucleotide	NULL
probes	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
STATS5-and	NULL
c-Rel-containing	NULL
complexes	NULL
was	NULL
determined	NULL
by	NULL
antibody	NULL
supershift	NULL
assays	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
,	NULL
also	NULL
see	NULL
Figures	NULL
2	NULL
and	NULL
3b	NULL
)	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Competition	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
radiolabeled	NULL
IL-2R	NULL
Â«	NULL
xB	NULL
probe	NULL
and	NULL
C8166	NULL
nuclear	NULL
extract	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presense	NULL
of	NULL
the	NULL
indicated	NULL
amounts	NULL
(	NULL
fold	NULL
molar	NULL
excess	NULL
)	NULL
of	NULL
the	NULL
indicated	NULL
unlabeled	NULL
oligonucleotide	NULL
probes	NULL
complex	NULL
(	NULL
Figure	NULL
4b	NULL
,	NULL
lanes	NULL
16	NULL
and	NULL
17	NULL
)	NULL
.	NULL

To	NULL
compare	NULL
the	NULL
binding	NULL
affinity	NULL
of	NULL
c-Rel	NULL
to	NULL
the	NULL
two	NULL
different	NULL
probes	NULL
,	NULL
a	NULL
parallel	NULL
competion	NULL
assay	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
P-radiolabeled	NULL
IL-2R	NULL
Â«	NULL
xB	NULL
as	NULL
probe	NULL
and	NULL
unlabeled	NULL
FoyR1	NULL
GAS	NULL
(	NULL
Figure	NULL
4Â¢	NULL
,	NULL
lanes	NULL
2-4	NULL
)	NULL
or	NULL
IL-2Ra	NULL
Â«	NULL
xB	NULL
(	NULL
lanes	NULL
5-7	NULL
)	NULL
as	NULL
competitors	NULL
.	NULL

The	NULL
xB	NULL
sequence	NULL
(	NULL
lane	NULL
5-7	NULL
)	NULL
exhibited	NULL
significantly	NULL
higher	NULL
competition	NULL
efficiency	NULL
than	NULL
the	NULL
GAS	NULL
sequence	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
c-Rel	NULL
and	NULL
STATS	NULL
bind	NULL
to	NULL
the	NULL
GAS	NULL
sequence	NULL
with	NULL
similar	NULL
affinity	NULL
,	NULL
whereas	NULL
c-Rel	NULL
has	NULL
much	NULL
higher	NULL
kB	NULL
binding	NULL
affinity	NULL
than	NULL
STATS	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
specificity	NULL
of	NULL
STATS5	NULL
and	NULL
c-Rel	NULL
was	NULL
examined	NULL
by	NULL
performing	NULL
competition	NULL
assays	NULL
with	NULL
a	NULL
probe	NULL
harboring	NULL
base	NULL
changes	NULL
.	NULL

When	NULL
three	NULL
cytidines	NULL
were	NULL
mutated	NULL
to	NULL
guanines	NULL
at	NULL
the	NULL
core	NULL
region	NULL
of	NULL
the	NULL
FcoyRl	NULL
GAS	NULL
site	NULL
(	NULL
Figure	NULL
4a	NULL
,	NULL
FoyRl	NULL
Mut	NULL
,	NULL
underlined	NULL
bases	NULL
)	NULL
,	NULL
it	NULL
abolished	NULL
the	NULL
ability	NULL
of	NULL
this	NULL
oligonucleotide	NULL
to	NULL
compete	NULL
for	NULL
binding	NULL
to	NULL
STATS5	NULL
as	NULL
well	NULL
as	NULL
to	NULL
c-Rel	NULL
(	NULL
lanes	NULL
18	NULL
and	NULL
19	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
both	NULL
STATS	NULL
and	NULL
c-Rel	NULL
to	NULL
this	NULL
probe	NULL
was	NULL
highly	NULL
specific	NULL
and	NULL
that	NULL
these	NULL
two	NULL
factors	NULL
may	NULL
bind	NULL
to	NULL
the	NULL
same	NULL
or	NULL
overlapping	NULL
sites	NULL
in	NULL
the	NULL
FcoyR1	NULL
sequence	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
c-Rel	NULL
also	NULL
binds	NULL
to	NULL
other	NULL
STAT	NULL
target	NULL
sequences	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
various	NULL
GAS-related	NULL
sequences	NULL
to	NULL
compete	NULL
with	NULL
the	NULL
FcyRI	NULL
probe	NULL
for	NULL
binding	NULL
to	NULL
c-Rel	NULL
was	NULL
analysed	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
prior	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
different	NULL
STAT	NULL
factors	NULL
may	NULL
bind	NULL
to	NULL
distinct	NULL
GAS	NULL
elements	NULL
(	NULL
Ihle	NULL
,	NULL
1996	NULL
;	NULL
O'Shea	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
STATS	NULL
specifically	NULL
binds	NULL
to	NULL
the	NULL
FcyR1	NULL
,	NULL
IRF-1	NULL
and	NULL
APRE	NULL
GAS	NULL
sites	NULL
but	NULL
not	NULL
to	NULL
other	NULL
GAS-like	NULL
sequences	NULL
,	NULL
such	NULL
as	NULL
Ly6E	NULL
,	NULL
Is	NULL
,	NULL
SIE	NULL
and	NULL
ISRE	NULL
(	NULL
Mui	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
(	NULL
see	NULL
Figure	NULL
4a	NULL
for	NULL
sequence	NULL
information	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
previous	NULL
studies	NULL
,	NULL
formation	NULL
of	NULL
the	NULL
STATS	NULL
complex	NULL
was	NULL
markedly	NULL
inhibited	NULL
by	NULL
the	NULL
IRF-1	NULL
,	NULL
APRE	NULL
,	NULL
as	NULL
well	NULL
as	NULL
FcoyR1	NULL
,	NULL
GAS	NULL
sequences	NULL
(	NULL
lanes	NULL
2-7	NULL
)	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
c-Rel	NULL
was	NULL
also	NULL
efficiently	NULL
competed	NULL
(	NULL
lanes	NULL
2-7	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
none	NULL
of	NULL
the	NULL
Is	NULL
group	NULL
of	NULL
GAS	NULL
sequences	NULL
(	NULL
Is	NULL
,	NULL
Ly6GE	NULL
,	NULL
SIE	NULL
and	NULL
ISRE	NULL
)	NULL
competed	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
STATS	NULL
or	NULL
c-Rel	NULL
complexes	NULL
(	NULL
lanes	NULL
8-15	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
c-Rel	NULL
appears	NULL
to	NULL
specifically	NULL
recognize	NULL
the	NULL
GAS	NULL
sequences	NULL
for	NULL
STATS	NULL
.	NULL

Transfected	NULL
c-Rel	NULL
binds	NULL
to	NULL
and	NULL
transactivates	NULL
the	NULL
FeyR1	NULL
GAS	NULL
element	NULL
To	NULL
evaluate	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
c-Rel	NULL
binding	NULL
to	NULL
GAS	NULL
sequence	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
c-Rel	NULL
on	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
FoyR1	NULL
GAS	NULL
element	NULL
was	NULL
analysed	NULL
by	NULL
reporter	NULL
gene	NULL
assays	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
Sa	NULL
,	NULL
transiently	NULL
expressed	NULL
c-Rel	NULL
bound	NULL
to	NULL
the	NULL
GAS	NULL
sequence	NULL
and	NULL
formed	NULL
a	NULL
DNA-protein	NULL
complex	NULL
(	NULL
Figure	NULL
Sa	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
which	NULL
could	NULL
be	NULL
supershifted	NULL
by	NULL
the	NULL
anti-c-Rel	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
confirmed	NULL
the	NULL
ability	NULL
of	NULL
c-Rel	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
GAS	NULL
sequence	NULL
.	NULL

Furthermore	NULL
,	NULL
this	NULL
specific	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
c-Rel	NULL
requires	NULL
its	NULL
N-terminal	NULL
sequences	NULL
,	NULL
since	NULL
deletion	NULL
of	NULL
32	NULL
amino	NULL
acids	NULL
from	NULL
the	NULL
N-terminus	NULL
of	NULL
c-Rel	NULL
generated	NULL
a	NULL
mutant	NULL
(	NULL
33-587	NULL
)	NULL
deficient	NULL
in	NULL
the	NULL
GAS	NULL
binding	NULL
(	NULL
Figure	NULL
Sa	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
deletion	NULL
of	NULL
up	NULL
to	NULL
280	NULL
amino	NULL
acids	NULL
from	NULL
the	NULL
C-terminus	NULL
of	NULL
the	NULL
molecule	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
c-Rel	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Parallel	NULL
luciferase	NULL
reporter	NULL
gene	NULL
assays	NULL
revealed	NULL
that	NULL
the	NULL
transiently	NULL
transfected	NULL
wildtype	NULL
c-Rel	NULL
potently	NULL
transactivated	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
FcyRI	NULL
GAS	NULL
sequences	NULL
(	NULL
Figure	NULL
5b	NULL
,	NULL
column	NULL
2	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
its	NULL
deficiency	NULL
in	NULL
DNA	NULL
binding	NULL
,	NULL
the	NULL
c-Rel	NULL
N-terminal	NULL
deletion	NULL
mutant	NULL
(	NULL
33-587	NULL
)	NULL
failed	NULL
to	NULL
transactivate	NULL
the	NULL
GAS	NULL
reporter	NULL
(	NULL
column	NULL
4	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
C-terminal	NULL
deletion	NULL
mutant	NULL
of	NULL
c-Rel	NULL
was	NULL
able	NULL
to	NULL
bind	NULL
the	NULL
GAS	NULL
sequence	NULL
(	NULL
Figure	NULL
5a	NULL
)	NULL
,	NULL
this	NULL
mutant	NULL
did	NULL
not	NULL
transactivate	NULL
the	NULL
reporter	NULL
(	NULL
Figure	NULL
5b	NULL
,	NULL
column	NULL
3	NULL
)	NULL
.	NULL

This	NULL
result	NULL
was	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
C-terminal	NULL
portion	NULL
of	NULL
c-Rel	NULL
contains	NULL
its	NULL
transactivation	NULL
domain	NULL
(	NULL
Doerre	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
protooncoprotein	NULL
c-Rel	NULL
serves	NULL
as	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
GAS	NULL
enhancer	NULL
element	NULL
,	NULL
and	NULL
this	NULL
function	NULL
of	NULL
c-Rel	NULL
requires	NULL
both	NULL
its	NULL
N-terminal	NULL
DNA	NULL
binding	NULL
and	NULL
C-terminal	NULL
transactivation	NULL
domains	NULL
.	NULL

We	NULL
also	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
RelA	NULL
on	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
GAS	NULL
enhancer	NULL
(	NULL
Figure	NULL
5Â¢c	NULL
)	NULL
and	NULL
showed	NULL
that	NULL
RelA	NULL
exhibited	NULL
much	NULL
lower	NULL
GAS	NULL
transactivation	NULL
activity	NULL
than	NULL
c-Rel	NULL
,	NULL
although	NULL
RelA	NULL
is	NULL
a	NULL
stronger	NULL
activator	NULL
of	NULL
the	NULL
xB	NULL
enhancer	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
c-Rel	NULL
is	NULL
the	NULL
predominant	NULL
GAS	NULL
binding	NULL
NF-xB	NULL
component	NULL
in	NULL
both	NULL
HTLV-I-infected	NULL
cells	NULL
and	NULL
cells	NULL
transiently	NULL
expressing	NULL
c-Rel	NULL
and	NULL
RelA	NULL
(	NULL
Figure	NULL
3a	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
GAS-binding	NULL
factors	NULL
correlates	NULL
with	NULL
HTLYV-I-induced	NULL
T-cell	NULL
proliferation	NULL
To	NULL
examine	NULL
the	NULL
physiological	NULL
relevance	NULL
of	NULL
our	NULL
findings	NULL
obtained	NULL
with	NULL
individual	NULL
HTLV-I-transformed	NULL
cell	NULL
lines	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
GAS-binding	NULL
factors	NULL
are	NULL
also	NULL
induced	NULL
along	NULL
with	NULL
HTLV-I-induced	NULL
T	NULL
cell	NULL
transforma-tion	NULL
.	NULL

For	NULL
these	NULL
studies	NULL
,	NULL
bulk	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
were	NULL
immortalized	NULL
with	NULL
HTLV-I	NULL
by	NULL
in	NULL
vitro	NULL
cultivation	NULL
with	NULL
y-irradiated	NULL
HTLV-I	NULL
donor	NULL
cells	NULL
(	NULL
MT-2	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
(	NULL
Persaud	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
proliferation	NULL
of	NULL
the	NULL
newly	NULL
immortalized	NULL
T	NULL
cells	NULL
stringently	NULL
requires	NULL
exogenous	NULL
IL-2	NULL
,	NULL
but	NULL
they	NULL
become	NULL
less	NULL
IL-2	NULL
dependent	NULL
and	NULL
proliferate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
suboptimal	NULL
amounts	NULL
of	NULL
exogenous	NULL
IL-2	NULL
after	NULL
about	NULL
4	NULL
months	NULL
in	NULL
culture	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Although	NULL
long	NULL
term	NULL
cultivation	NULL
of	NULL
these	NULL
cells	NULL
required	NULL
exogenous	NULL
IL-2	NULL
,	NULL
these	NULL
cells	NULL
could	NULL
proliferate	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-2	NULL
or	NULL
mitogenic	NULL
stimuli	NULL
for	NULL
short	NULL
periods	NULL
(	NULL
up	NULL
to	NULL
96	NULL
h	NULL
,	NULL
Figure	NULL
6a	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
sharp	NULL
contrast	NULL
,	NULL
the	NULL
normal	NULL
uninfected	NULL
T	NULL
cells	NULL
did	NULL
not	NULL
proliferate	NULL
unless	NULL
stimulated	NULL
with	NULL
mitogens	NULL
(	NULL
Figure	NULL
6a	NULL
)	NULL
.	NULL

Similar	NULL
IL-2-independent	NULL
growth	NULL
was	NULL
previously	NULL
also	NULL
demonstrated	NULL
with	NULL
HTLV-TI-infected	NULL
antigen-specific	NULL
T-cell	NULL
clones	NULL
(	NULL
Hollsberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

We	NULL
then	NULL
analysed	NULL
the	NULL
GAS-binding	NULL
activity	NULL
in	NULL
both	NULL
the	NULL
normal	NULL
and	NULL
HTLV-I-immortalized	NULL
T	NULL
cells	NULL
by	NULL
EMSA	NULL
using	NULL
the	NULL
FcyRl	NULL
GAS	NULL
element	NULL
as	NULL
probe	NULL
.	NULL

In	NULL
IL-2-starved	NULL
normal	NULL
T	NULL
cells	NULL
,	NULL
no	NULL
GAS-binding	NULL
activity	NULL
was	NULL
detected	NULL
(	NULL
Figure	NULL
6b	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Upon	NULL
stimulation	NULL
with	NULL
the	NULL
mitogens	NULL
,	NULL
GAS-binding	NULL
factors	NULL
were	NULL
clearly	NULL
induced	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Antibody	NULL
supershift	NULL
assays	NULL
showed	NULL
that	NULL
the	NULL
GAS-binding	NULL
complexes	NULL
formed	NULL
in	NULL
normal	NULL
T	NULL
cells	NULL
treated	NULL
for	NULL
8	NULL
h	NULL
were	NULL
supershifted	NULL
by	NULL
antibodies	NULL
for	NULL
both	NULL
STATS	NULL
(	NULL
Figure	NULL
6Â¢	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
but	NULL
did	NULL
not	NULL
react	NULL
with	NULL
a	NULL
preimmune	NULL
serum	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
an	NULL
unrelated	NULL
immune	NULL
serum	NULL
(	NULL
anti-NF-ATp	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
mitogen	NULL
stimulated	NULL
T-cell	NULL
proliferation	NULL
was	NULL
correlated	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
GAS-binding	NULL
factors	NULL
including	NULL
both	NULL
STATS	NULL
and	NULL
c-Rel	NULL
.	NULL

Interestingly	NULL
,	NULL
strong	NULL
GAS-binding	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
untreated	NULL
HTLV-I-immortalized	NULL
T	NULL
cells	NULL
Functional	NULL
binding	NULL
of	NULL
c-Rel	NULL
to	NULL
STATS	NULL
target	NULL
sequences	NULL
SC	NULL
Sun	NULL
et	NULL
al	NULL
(	NULL
Figure	NULL
6b	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
PHA	NULL
did	NULL
not	NULL
significantly	NULL
alter	NULL
the	NULL
pattern	NULL
of	NULL
the	NULL
GAS-binding	NULL
complex	NULL
formation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

a	NULL
1	NULL
2	NULL
3	NULL
4	NULL
U	NULL
1	NULL
U	NULL
U	NULL
NS	NULL
44	NULL
>	NULL
\I	NULL
Â»	NULL
\Â¢1	NULL
,	NULL
|	NULL
,	NULL
\0~\0~	NULL
(	NULL
G	NULL
'	NULL
C	NULL
.r	NULL
**	NULL
*7*B	NULL
7	NULL
5	NULL
&	NULL
3	NULL
,	NULL
b	NULL
C	NULL
100	NULL
100	NULL
C	NULL
]	NULL
2	NULL
9	NULL
-	NULL
so	NULL
so	NULL
.	NULL

,	NULL
g	NULL
a	NULL
jung	NULL
rg	NULL
3	NULL
-	NULL
60	NULL
.	NULL

60	NULL
|	NULL
a	NULL
&	NULL
3	NULL
-	NULL
40	NULL
|	NULL
ao	NULL
<	NULL
4	NULL
L	NULL
Fe	NULL
Â§	NULL
-	NULL
20	NULL
20	NULL
&	NULL
*C	NULL
[	NULL
-	NULL
]	NULL
fis	NULL
:	NULL
o	NULL
|	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
1	NULL
2	NULL
3	NULL
a	NULL
-	NULL
fp	NULL
oq	NULL
o	NULL
a	NULL
n	NULL
o	NULL
z	NULL
&	NULL
R	NULL
Po	NULL
?	NULL

i	NULL
mas	NULL
Jua	NULL
mas	NULL
a	NULL
land	NULL
>	NULL
Â©	NULL
am	NULL
am	NULL
=	NULL
#	NULL
A	NULL
5	NULL
Fla	NULL
8	NULL
m	NULL
g	NULL
i	NULL
e	NULL
Go	NULL
3	NULL
Figure	NULL
5	NULL
-	NULL
Transfected	NULL
c-Rel	NULL
binds	NULL
to	NULL
and	NULL
transactivates	NULL
the	NULL
FoyRI1	NULL
GAS	NULL
enhancer	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Binding	NULL
of	NULL
c-Rel	NULL
to	NULL
FeyR1	NULL
GAS	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
a	NULL
parental	NULL
pCMV4	NULL
plasmid	NULL
vector	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
the	NULL
pCMV4-based	NULL
cDNA	NULL
expression	NULL
vectors	NULL
encoding	NULL
wildtype	NULL
or	NULL
mutant	NULL
forms	NULL
of	NULL
c-Rel	NULL
.	NULL

After	NULL
40	NULL
h	NULL
nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
transfectants	NULL
,	NULL
the	NULL
GAS	NULL
binding	NULL
activity	NULL
was	NULL
analysed	NULL
by	NULL
EMSA	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
c-Rel	NULL
and	NULL
its	NULL
mutants	NULL
was	NULL
confirmed	NULL
by	NULL
a	NULL
parallel	NULL
immunoblotting	NULL
assay	NULL
using	NULL
a	NULL
peptide-specific	NULL
anti-c-Rel	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Activation	NULL
of	NULL
a	NULL
GAS-driven	NULL
reporter	NULL
by	NULL
c-Rel	NULL
.	NULL

F9	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
luciferase	NULL
reporter	NULL
driven	NULL
by	NULL
the	NULL
FeyRI	NULL
STAT	NULL
enhancer	NULL
(	NULL
GRR-STAT-Luc	NULL
)	NULL
along	NULL
with	NULL
either	NULL
the	NULL
parental	NULL
vector	NULL
pCMV4	NULL
or	NULL
cDNA	NULL
expression	NULL
vectors	NULL
encoding	NULL
the	NULL
wildtype	NULL
or	NULL
truncated	NULL
forms	NULL
of	NULL
c-Rel	NULL
.	NULL

After	NULL
40	NULL
h	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

Luciferase	NULL
activity	NULL
is	NULL
presented	NULL
as	NULL
fold	NULL
induction	NULL
relative	NULL
to	NULL
the	NULL
basal	NULL
level	NULL
measured	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
pCMV4	NULL
(	NULL
7970	NULL
c.p.m	NULL
.	NULL
)	NULL

.	NULL

The	NULL
values	NULL
shown	NULL
are	NULL
means+standard	NULL
errors	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
c	NULL
)	NULL
RelA	NULL
is	NULL
a	NULL
weak	NULL
GAS	NULL
transactivator	NULL
.	NULL

F9	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
GRR-STAT-Luc	NULL
along	NULL
with	NULL
either	NULL
pCMV4	NULL
or	NULL
expression	NULL
vectors	NULL
encoding	NULL
c-Rel	NULL
or	NULL
RelA	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
b	NULL
Functional	NULL
binding	NULL
of	NULL
c-Rel	NULL
to	NULL
STATS	NULL
target	NULL
sequences	NULL
SC	NULL
Sun	NULL
et	NULL
al	NULL
1406	NULL
Supershift	NULL
assays	NULL
revealed	NULL
that	NULL
these	NULL
complexes	NULL
contained	NULL
predominantly	NULL
c-Rel	NULL
(	NULL
Figure	NULL
6Â¢c	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
but	NULL
only	NULL
low	NULL
amounts	NULL
of	NULL
STATS	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
the	NULL
IL-2-independent	NULL
proliferation	NULL
of	NULL
HTLV-I-immortalized	NULL
T	NULL
cells	NULL
was	NULL
correlated	NULL
with	NULL
the	NULL
enhanced	NULL
binding	NULL
of	NULL
c-Rel	NULL
to	NULL
the	NULL
STATS	NULL
target	NULL
enhancer	NULL
.	NULL

A490	NULL
(	NULL
units	NULL
)	NULL
o	NULL
_	NULL
(	NULL
VHI/VWNd	NULL
)	NULL
JL	NULL
~	NULL
ATLLH/L	NULL
Â«	NULL
-	NULL
Discussion	NULL
Antigen-stimulated	NULL
T-cell	NULL
growth	NULL
is	NULL
tightly	NULL
controlled	NULL
by	NULL
the	NULL
inducible	NULL
secretion	NULL
of	NULL
IL-2	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
its	NULL
high	NULL
affinity	NULL
receptor	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
IL-2	NULL
to	NULL
its	NULL
receptor	NULL
triggers	NULL
activation	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
,	NULL
including	NULL
JAKs	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
activate	NULL
the	NULL
nuclear	NULL
Cells	NULL
[	NULL
=	NULL
-	NULL
>	NULL
(	NULL
23	NULL
-	NULL
Â»	NULL
|T/HTLV	NULL
STATS	NULL
Â»	NULL
c-Rel-47	NULL
#	NULL
NS	NULL
Treatmentk	NULL
â	NULL
l	NULL
'	NULL
;	NULL
Ã©\	NULL
â	NULL
94\47	NULL
.	NULL

Pï¬dA	NULL
PHA	NULL
'	NULL
(	NULL
1	NULL
:	NULL
'	NULL
(	NULL
PMA/PHA	NULL
)	NULL
1	NULL
r	NULL
?	NULL

d	NULL
T/HTLV	NULL
5	NULL
Â§	NULL
7	NULL
Â§	NULL
to	NULL
tab	NULL
#	NULL
(	NULL
|	NULL
\	NULL
\	NULL
\	NULL
\	NULL
&	NULL
_	NULL
S	NULL
&	NULL
\	NULL
â	NULL
FQI'QQ	NULL
``	NULL
e	NULL
4/1396	NULL
?	NULL
)	NULL

``	NULL
6	NULL
a	NULL
,	NULL
Q9	NULL
!	NULL

417	NULL
%	NULL
â	NULL
1	NULL
)	NULL
~Â°/	NULL
4	NULL
)	NULL
.	NULL

Figure	NULL
6	NULL
Proliferation	NULL
and	NULL
GAS-binding	NULL
detected	NULL
with	NULL
normal	NULL
and	NULL
HTLV-I-immortalized	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Cell	NULL
proliferation	NULL
assays	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
were	NULL
immortalized	NULL
with	NULL
HTLV-I	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

The	NULL
immortalized	NULL
(	NULL
column	NULL
3	NULL
)	NULL
as	NULL
well	NULL
as	NULL
normal	NULL
uninfected	NULL
T	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
were	NULL
starved	NULL
for	NULL
30	NULL
h	NULL
in	NULL
media	NULL
lacking	NULL
IL-2	NULL
and	NULL
then	NULL
either	NULL
left	NULL
untreated	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
or	NULL
incubated	NULL
with	NULL
PMA	NULL
plus	NULL
PHA	NULL
for	NULL
36	NULL
h	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
proliferation	NULL
rate	NULL
of	NULL
these	NULL
cells	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
non-radioactive	NULL
assay	NULL
reagent	NULL
(	NULL
Promega	NULL
,	NULL
CellTiter	NULL
96	NULL
AQ	NULL
One	NULL
)	NULL
and	NULL
is	NULL
expressed	NULL
as	NULL
absorbance	NULL
at	NULL
490	NULL
nm	NULL
.	NULL

(	NULL
b	NULL
)	NULL
EMSA	NULL
of	NULL
GAS-binding	NULL
factors	NULL
.	NULL

The	NULL
IL-2	NULL
starved	NULL
normal	NULL
and	NULL
HTLV-I-immortalized	NULL
T	NULL
cells	NULL
were	NULL
either	NULL
not	NULL
treated	NULL
(	NULL
NT	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
PMA/PHA	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
these	NULL
cells	NULL
and	NULL
analysed	NULL
by	NULL
EMSA	NULL
using	NULL
the	NULL
FceyR1	NULL
GAS	NULL
probe	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Supershift	NULL
analyses	NULL
of	NULL
the	NULL
GAS-binding	NULL
factors	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
preimmune	NULL
or	NULL
immune	NULL
sera	NULL
using	NULL
nuclear	NULL
extracts	NULL
of	NULL
either	NULL
stimulated	NULL
normal	NULL
T	NULL
cells	NULL
(	NULL
PMA/PHA	NULL
,	NULL
8	NULL
h	NULL
)	NULL
or	NULL
untreated	NULL
HTLV-I	NULL
immortalized	NULL
T	NULL
cells	NULL
expression	NULL
and	NULL
function	NULL
of	NULL
STATS	NULL
and	NULL
STAT3	NULL
transcription	NULL
factors	NULL
(	NULL
Lin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

These	NULL
factors	NULL
activate	NULL
target	NULL
genes	NULL
driven	NULL
by	NULL
the	NULL
GAS	NULL
enhancer	NULL
element	NULL
,	NULL
thus	NULL
contributing	NULL
to	NULL
IL-2-induced	NULL
cell	NULL
proliferation	NULL
.	NULL

Infection	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
HTLV-I	NULL
is	NULL
associated	NULL
with	NULL
an	NULL
initial	NULL
phase	NULL
of	NULL
IL-2-dependent	NULL
polyclonal	NULL
cell	NULL
growth	NULL
,	NULL
which	NULL
is	NULL
believed	NULL
to	NULL
facilitate	NULL
occurrence	NULL
of	NULL
secondary	NULL
events	NULL
allowing	NULL
the	NULL
infected	NULL
cells	NULL
to	NULL
progress	NULL
to	NULL
an	NULL
IL-2-independent	NULL
stage	NULL
.	NULL

The	NULL
mechanism	NULL
mediating	NULL
the	NULL
IL-2-independent	NULL
growth	NULL
of	NULL
HTLV-I-transformed	NULL
cells	NULL
is	NULL
elusive	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
generally	NULL
believed	NULL
that	NULL
deregulation	NULL
of	NULL
cellular	NULL
transcription	NULL
factors	NULL
and	NULL
abnormal	NULL
induction	NULL
of	NULL
their	NULL
target	NULL
genes	NULL
may	NULL
play	NULL
a	NULL
role	NULL
(	NULL
Ressler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
JAK/STAT	NULL
system	NULL
is	NULL
constitutively	NULL
activated	NULL
in	NULL
certain	NULL
HTLV-I-transformed	NULL
T	NULL
cell	NULL
lines	NULL
(	NULL
Migone	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Takemoto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Xu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
thus	NULL
suggesting	NULL
that	NULL
constitutive	NULL
STAT	NULL
activation	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
HTLV-I-induced	NULL
IL-2-independent	NULL
T-cell	NULL
growth	NULL
.	NULL

However	NULL
,	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
that	NULL
STAT	NULL
activation	NULL
does	NULL
not	NULL
occur	NULL
in	NULL
T	NULL
cells	NULL
transformed	NULL
by	NULL
HTLV-II	NULL
(	NULL
an	NULL
HTLV-I	NULL
related	NULL
virus	NULL
)	NULL
or	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
HTLV-I	NULL
(	NULL
Mulloy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Even	NULL
some	NULL
of	NULL
the	NULL
HTLV-I-transformed	NULL
T-cell	NULL
lines	NULL
lack	NULL
detectable	NULL
JAK/STAT	NULL
activity	NULL
(	NULL
Mulloy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
and	NULL
this	NULL
study	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
the	NULL
involvement	NULL
of	NULL
additional	NULL
mechanisms	NULL
in	NULL
HTLV-I-induced	NULL
cell	NULL
growth	NULL
.	NULL

The	NULL
NF-	NULL
Â«	NULL
xB/Rel	NULL
enhancer	NULL
binding	NULL
proteins	NULL
have	NULL
also	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
growth	NULL
control	NULL
of	NULL
HTLV-I-transformed	NULL
cells	NULL
.	NULL

These	NULL
factors	NULL
are	NULL
constitutively	NULL
activated	NULL
almost	NULL
exclusively	NULL
in	NULL
HTLV-I-	NULL
and	NULL
Tax-transformed	NULL
cells	NULL
(	NULL
Ressler	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-xB/Rel	NULL
expression	NULL
using	NULL
specific	NULL
antisense	NULL
oligonu-cleotides	NULL
potently	NULL
interferes	NULL
with	NULL
the	NULL
growth	NULL
of	NULL
tumor	NULL
cells	NULL
induced	NULL
by	NULL
both	NULL
HTLV-I	NULL
and	NULL
Tax	NULL
(	NULL
Kitajima	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

It	NULL
has	NULL
not	NULL
been	NULL
defined	NULL
how	NULL
NF-xB/Rel	NULL
participates	NULL
in	NULL
the	NULL
growth	NULL
control	NULL
of	NULL
HTLV-I-transformed	NULL
cells	NULL
.	NULL

A	NULL
known	NULL
mechanism	NULL
for	NULL
c-Rel-induced	NULL
normal	NULL
T-cell	NULL
proliferation	NULL
is	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
and	NULL
its	NULL
high	NULL
affinity	NULL
receptor	NULL
(	NULL
Kontgen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
triggers	NULL
the	NULL
activation	NULL
of	NULL
various	NULL
growth-regulatory	NULL
factors	NULL
,	NULL
including	NULL
STATS	NULL
.	NULL

However	NULL
,	NULL
except	NULL
during	NULL
the	NULL
early	NULL
stage	NULL
,	NULL
the	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
usually	NULL
do	NULL
not	NULL
produce	NULL
IL-2	NULL
nor	NULL
require	NULL
IL-2	NULL
for	NULL
growth	NULL
(	NULL
Hollsberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Uchiyama	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
may	NULL
suggest	NULL
a	NULL
potential	NULL
mechanism	NULL
by	NULL
which	NULL
NF-xB/Rel	NULL
participates	NULL
in	NULL
the	NULL
control	NULL
of	NULL
IL-2-independent	NULL
T-cell	NULL
growth	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
certain	NULL
NF-xB/Rel	NULL
members	NULL
,	NULL
especially	NULL
c-Rel	NULL
,	NULL
are	NULL
able	NULL
to	NULL
functionally	NULL
interact	NULL
with	NULL
target	NULL
enhancers	NULL
(	NULL
GAS	NULL
)	NULL
of	NULL
STATS	NULL
.	NULL

Remarkably	NULL
,	NULL
c-Rel	NULL
serves	NULL
as	NULL
a	NULL
predominant	NULL
GAS-binding	NULL
factor	NULL
in	NULL
a	NULL
number	NULL
of	NULL
HTLV-I-transformed	NULL
T-cell	NULL
lines	NULL
analysed	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
contribution	NULL
of	NULL
c-Rel	NULL
,	NULL
the	NULL
GAS	NULL
site	NULL
is	NULL
constitutively	NULL
occupied	NULL
in	NULL
all	NULL
these	NULL
HTLV-I-transformed	NULL
cell	NULL
lines	NULL
,	NULL
even	NULL
though	NULL
STATS	NULL
and	NULL
STAT3	NULL
are	NULL
only	NULL
activated	NULL
in	NULL
some	NULL
of	NULL
them	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
a	NULL
recent	NULL
protein	NULL
structural	NULL
study	NULL
,	NULL
which	NULL
demonstrates	NULL
that	NULL
STAT	NULL
and	NULL
the	NULL
Rel	NULL
proteins	NULL
share	NULL
striking	NULL
structural	NULL
similarity	NULL
even	NULL
though	NULL
they	NULL
have	NULL
no	NULL
obvious	NULL
sequence	NULL
homology	NULL
(	NULL
Becker	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
suggested	NULL
that	NULL
STAT	NULL
and	NULL
Rel	NULL
proteins	NULL
differ	NULL
in	NULL
their	NULL
DNA	NULL
binding	NULL
constants	NULL
,	NULL
which	NULL
are	NULL
in	NULL
the	NULL
nanomolar	NULL
and	NULL
picomolar	NULL
ranges	NULL
for	NULL
STAT	NULL
's	NULL
and	NULL
Rel	NULL
proteins	NULL
,	NULL
respectively	NULL
(	NULL
Becker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Our	NULL
Functional	NULL
binding	NULL
of	NULL
c-Rel	NULL
to	NULL
STATS	NULL
target	NULL
sequences	NULL
SC	NULL
Sun	NULL
et	NULL
al	NULL
competition	NULL
assays	NULL
also	NULL
show	NULL
that	NULL
c-Rel	NULL
appears	NULL
to	NULL
have	NULL
higher	NULL
affinity	NULL
to	NULL
the	NULL
IL-2R	NULL
Â«	NULL
xB	NULL
site	NULL
compared	NULL
to	NULL
its	NULL
binding	NULL
affinity	NULL
to	NULL
the	NULL
FeyR1	NULL
GAS	NULL
sequence	NULL
(	NULL
Figure	NULL
4c	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
c-Rel	NULL
to	NULL
the	NULL
GAS	NULL
enhancer	NULL
is	NULL
functional	NULL
since	NULL
c-Rel	NULL
potently	NULL
activates	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
FoyR1l	NULL
GAS	NULL
in	NULL
transiently	NULL
transfected	NULL
cells	NULL
(	NULL
Figure	NULL
5b	NULL
)	NULL
.	NULL

Given	NULL
its	NULL
abundant	NULL
expression	NULL
in	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
,	NULL
c-Rel	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
certain	NULL
STATS	NULL
target	NULL
genes	NULL
in	NULL
these	NULL
virus-infected	NULL
cells	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
suggests	NULL
that	NULL
STAT6	NULL
physically	NULL
interacts	NULL
with	NULL
the	NULL
p50	NULL
and	NULL
RelA	NULL
subunits	NULL
of	NULL
NF-xB	NULL
and	NULL
functionally	NULL
cooperate	NULL
with	NULL
NF-xB	NULL
in	NULL
IL-4-induced	NULL
transcription	NULL
(	NULL
Shen	NULL
and	NULL
Stavnezer	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
have	NULL
not	NULL
been	NULL
able	NULL
to	NULL
detect	NULL
interaction	NULL
between	NULL
c-Rel	NULL
and	NULL
STATS	NULL
using	NULL
either	NULL
co-immunopre-cipitation	NULL
or	NULL
antibody	NULL
supershift	NULL
assays	NULL
(	NULL
Figure	NULL
6Â¢	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Of	NULL
course	NULL
,	NULL
our	NULL
data	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
these	NULL
two	NULL
growth-related	NULL
transcription	NULL
factors	NULL
function	NULL
cooperatively	NULL
on	NULL
certain	NULL
gene	NULL
promoters	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Cells	NULL
and	NULL
culture	NULL
conditions	NULL
Human	NULL
Jurkat	NULL
leukemic	NULL
T	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
(	NULL
complete	NULL
RPMI	NULL
)	NULL
.	NULL

Murine	NULL
HT2	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
complete	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
25	NULL
units	NULL
of	NULL
human	NULL
recombinant	NULL
IL-2	NULL
(	NULL
Biological	NULL
Resources	NULL
Branch	NULL
,	NULL
NCI	NULL
)	NULL
and	NULL
55	NULL
um	NULL
fB-mercaptoethanol	NULL
.	NULL

F9	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
Iscove	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
(	NULL
complete	NULL
Iscove	NULL
's	NULL
medium	NULL
)	NULL
.	NULL

C8166	NULL
(	NULL
Salahuddin	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1983	NULL
)	NULL
,	NULL
HUTI02	NULL
(	NULL
Gazdar	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1980	NULL
)	NULL
,	NULL
MT-2	NULL
(	NULL
Miyoshi	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1981	NULL
)	NULL
and	NULL
SLB-1	NULL
(	NULL
Koeffler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
)	NULL
are	NULL
HTLV-I-transformed	NULL
human	NULL
T-cell	NULL
lines	NULL
,	NULL
which	NULL
proliferate	NULL
independent	NULL
of	NULL
IL-2	NULL
.	NULL

The	NULL
C8166	NULL
,	NULL
HUTI102	NULL
and	NULL
MT-2	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
complete	NULL
RPMI	NULL
medium	NULL
,	NULL
and	NULL
the	NULL
SLB-1	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
complete	NULL
Iscove	NULL
's	NULL
medium	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
were	NULL
prepared	NULL
from	NULL
T-cell	NULL
enriched	NULL
human	NULL
blood	NULL
(	NULL
Biological	NULL
Specialty	NULL
Corporation	NULL
,	NULL
Colmar	NULL
)	NULL
with	NULL
a	NULL
Ficoll-Hypaque	NULL
gradient	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
36	NULL
h	NULL
with	NULL
phytohemaglutinin	NULL
(	NULL
PHA	NULL
,	NULL
2	NULL
ug/ml	NULL
!	NULL
)	NULL

and	NULL
then	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
20	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
antibiotics	NULL
and	NULL
25	NULL
units/ml	NULL
of	NULL
human	NULL
recombinant	NULL
IL-2	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
PBMC	NULL
usually	NULL
continuously	NULL
grew	NULL
for	NULL
2-4	NULL
weeks	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
exogenous	NULL
IL-2	NULL
.	NULL

Proliferating	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
PBMC	NULL
by	NULL
negative	NULL
selection	NULL
using	NULL
the	NULL
Enrichment	NULL
Immunecolums	NULL
(	NULL
Biotex	NULL
Laboratories	NULL
Inc.	NULL
,	NULL
Edmonton	NULL
,	NULL
Alberta	NULL
)	NULL
.	NULL

For	NULL
obtaining	NULL
resting	NULL
PBMC	NULL
or	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
RPMI	NULL
lacking	NULL
IL-2	NULL
followed	NULL
by	NULL
incubating	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
for	NULL
24-30	NULL
h.	NULL
In	NULL
vitro	NULL
immortalization	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
HTLV-I	NULL
In	NULL
vitro	NULL
immortalization	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
HTLV-I	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Merl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
;	NULL
Persaud	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
PHA-stimulated	NULL
PBMC	NULL
was	NULL
cocultured	NULL
with	NULL
y-irradiated	NULL
HTLV-I	NULL
donor	NULL
cells	NULL
(	NULL
MT-2	NULL
)	NULL
in	NULL
the	NULL
IL-2-containing	NULL
RPMI	NULL
medium	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
diluted	NULL
when	NULL
the	NULL
medium	NULL
become	NULL
acidic	NULL
(	NULL
as	NULL
indicated	NULL
by	NULL
its	NULL
color	NULL
change	NULL
)	NULL
.	NULL

As	NULL
controls	NULL
,	NULL
PBMC	NULL
and	NULL
y-irradiated	NULL
MT-2	NULL
cells	NULL
were	NULL
cultured	NULL
separately	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
.	NULL

As	NULL
1407	NULL
Functional	NULL
binding	NULL
of	NULL
c-Rel	NULL
to	NULL
STATS	NULL
target	NULL
sequences	NULL
SC	NULL
Sun	NULL
et	NULL
al	NULL
1408	NULL
expected	NULL
(	NULL
Merl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
;	NULL
Persaud	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
immortalized	NULL
T	NULL
cells	NULL
started	NULL
dominating	NULL
the	NULL
PBMC/MT-2	NULL
coculture	NULL
after	NULL
4-5	NULL
weeks	NULL
.	NULL

These	NULL
immortalized	NULL
cells	NULL
were	NULL
continuously	NULL
proliferating	NULL
when	NULL
exogenous	NULL
IL-2	NULL
was	NULL
provided	NULL
,	NULL
a	NULL
characteristic	NULL
of	NULL
T	NULL
cells	NULL
at	NULL
early	NULL
stage	NULL
of	NULL
HTLV-I	NULL
infection	NULL
(	NULL
Feuer	NULL
and	NULL
Chen	NULL
,	NULL
1992	NULL
;	NULL
Sodroski	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

Under	NULL
the	NULL
same	NULL
culturing	NULL
conditions	NULL
,	NULL
the	NULL
uninfected	NULL
control	NULL
PBMC	NULL
usually	NULL
cease	NULL
growth	NULL
between	NULL
2-4	NULL
weeks	NULL
,	NULL
and	NULL
the	NULL
y-irradiated	NULL
MT-2	NULL
cells	NULL
never	NULL
grew	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
HTLV-I-immortalized	NULL
T	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
IL-2	NULL
and	NULL
used	NULL
as	NULL
bulk	NULL
population	NULL
after	NULL
about	NULL
4	NULL
months	NULL
.	NULL

Normal	NULL
T	NULL
cells	NULL
were	NULL
collected	NULL
after	NULL
1-2	NULL
weeks	NULL
of	NULL
cultivation	NULL
and	NULL
frozen	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
dimethyl	NULL
sulfoxide	NULL
until	NULL
use	NULL
.	NULL

To	NULL
re-start	NULL
the	NULL
culture	NULL
,	NULL
the	NULL
frozen	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
RPMI	NULL
medium	NULL
and	NULL
then	NULL
cultured	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
supplemented	NULL
with	NULL
IL-2	NULL
.	NULL

Nuclear	NULL
extract	NULL
preparation	NULL
and	NULL
electrophoresis	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
Normal	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
and	NULL
HTLV-I-immortalized	NULL
T	NULL
cells	NULL
were	NULL
starved	NULL
for	NULL
30	NULL
h	NULL
in	NULL
RPMI	NULL
growth	NULL
medium	NULL
lacking	NULL
exogenous	NULL
IL-2	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
either	NULL
not	NULL
treated	NULL
or	NULL
incubated	NULL
with	NULL
PMA	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

plus	NULL
PHA	NULL
(	NULL
1	NULL
ug/	NULL
ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
nuclear	NULL
extract	NULL
preparation	NULL
.	NULL

Jurkat	NULL
,	NULL
HT2	NULL
and	NULL
IL-2-independent	NULL
HTLV-I-transformed	NULL
T	NULL
cell	NULL
lines	NULL
were	NULL
collected	NULL
directly	NULL
from	NULL
their	NULL
culturing	NULL
media	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
these	NULL
cells	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Schreiber	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Human	NULL
293	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
DEAE-dextran	NULL
(	NULL
Holbrook	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
with	NULL
cDNA	NULL
expression	NULL
vectors	NULL
encoding	NULL
the	NULL
wildtype	NULL
or	NULL
mutant	NULL
forms	NULL
of	NULL
c-Rel	NULL
(	NULL
Doerre	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
collected	NULL
for	NULL
nuclear	NULL
extract	NULL
preparation	NULL
40	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
by	NULL
incubating	NULL
nuclear	NULL
extracts	NULL
isolated	NULL
from	NULL
the	NULL
various	NULL
cell	NULL
types	NULL
(	NULL
~10	NULL
ug	NULL
for	NULL
untransfected	NULL
T	NULL
cells	NULL
and	NULL
~5	NULL
ug	NULL
for	NULL
transfected	NULL
293	NULL
cells	NULL
)	NULL
with	NULL
P-radiolabeled	NULL
wildtype	NULL
FoyR1	NULL
STAT	NULL
probe	NULL
(	NULL
Figure	NULL
3a	NULL
,	NULL
FeyRIWT	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
10	NULL
min	NULL
followed	NULL
by	NULL
resolving	NULL
the	NULL
DNA-protein	NULL
References	NULL
Akagi	NULL
T	NULL
,	NULL
Ono	NULL
H	NULL
,	NULL
Nyunoya	NULL
H	NULL
and	NULL
Shimotohno	NULL
K.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
14	NULL
,	NULL
2071-2078	NULL
.	NULL

Becker	NULL
S	NULL
,	NULL
Groner	NULL
B	NULL
and	NULL
Miiller	NULL
CW	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
394	NULL
,	NULL
145-151	NULL
.	NULL

Beg	NULL
AA	NULL
and	NULL
Baldwin	NULL
Jr	NULL
,	NULL
AS	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
,	NULL
2064-2070	NULL
.	NULL

Brockman	NULL
JA	NULL
,	NULL
Scherer	NULL
DC	NULL
,	NULL
McKinsey	NULL
TA	NULL
,	NULL
Hall	NULL
SM	NULL
,	NULL
Qi	NULL
X	NULL
,	NULL
Lee	NULL
WY	NULL
and	NULL
Ballard	NULL
DA	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
2809-2818	NULL
.	NULL

Darnell	NULL
Jr	NULL
JE	NULL
,	NULL
Kerr	NULL
IM	NULL
and	NULL
Stark	NULL
GR	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
264	NULL
,	NULL
1415-1421	NULL
.	NULL

Doerre	NULL
S	NULL
,	NULL
Sista	NULL
P	NULL
,	NULL
Sun	NULL
S-C	NULL
,	NULL
Ballard	NULL
DW	NULL
and	NULL
Greene	NULL
WC	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
1023-1027	NULL
.	NULL

Feuer	NULL
G	NULL
and	NULL
Chen	NULL
ISY	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1114	NULL
,	NULL
223-233	NULL
.	NULL

Fujii	NULL
H	NULL
,	NULL
Nakagawa	NULL
Y	NULL
,	NULL
Schindler	NULL
U	NULL
,	NULL
Kawahara	NULL
A	NULL
,	NULL
Mori	NULL
H	NULL
,	NULL
Bouilleux	NULL
F	NULL
,	NULL
Groner	NULL
B	NULL
,	NULL
Ihle	NULL
JN	NULL
,	NULL
Minami	NULL
Y	NULL
,	NULL
Miyazaki	NULL
T	NULL
and	NULL
Taniguchi	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
,	NULL
5482-5486	NULL
.	NULL

Ganchi	NULL
PA	NULL
,	NULL
Sun	NULL
S-C	NULL
,	NULL
Greene	NULL
WC	NULL
and	NULL
Ballard	NULL
DW	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
,	NULL
3	NULL
,	NULL
1339-1352	NULL
.	NULL

Gazdar	NULL
AF	NULL
,	NULL
Carney	NULL
DN	NULL
,	NULL
Bunn	NULL
PA	NULL
,	NULL
Russell	NULL
EK	NULL
and	NULL
Jaffe	NULL
GP	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
55	NULL
,	NULL
409-417	NULL
.	NULL

Gilmore	NULL
TD	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
62	NULL
,	NULL
841-843	NULL
.	NULL

Good	NULL
L	NULL
and	NULL
Sun	NULL
S-C.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
70	NULL
,	NULL
2730-2735	NULL
.	NULL

Holbrook	NULL
N	NULL
,	NULL
Gulino	NULL
A	NULL
and	NULL
Ruscetti	NULL
F.	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

Virology	NULL
,	NULL
157	NULL
,	NULL
211-219.	NULL
complexes	NULL
on	NULL
native	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
Ganchi	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

For	NULL
antibody	NULL
'supershift	NULL
'	NULL
assays	NULL
,	NULL
0.5	NULL
ul	NULL
of	NULL
antisera	NULL
for	NULL
NF-	NULL
Â«	NULL
xB	NULL
or	NULL
STAT	NULL
proteins	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
Inc.	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
EMSA	NULL
reaction	NULL
5	NULL
min	NULL
before	NULL
electro-phoresis	NULL
.	NULL

Competition	NULL
assays	NULL
were	NULL
performed	NULL
by	NULL
including	NULL
excess	NULL
unlabeled	NULL
double	NULL
stranded	NULL
oligonucleotide	NULL
probes	NULL
in	NULL
the	NULL
reaction	NULL
.	NULL

Oligonucleotide	NULL
probes	NULL
used	NULL
in	NULL
EMSA	NULL
and	NULL
competition	NULL
assays	NULL
are	NULL
indicated	NULL
in	NULL
Figure	NULL
4a	NULL
.	NULL

Luciferase	NULL
reporter	NULL
gene	NULL
assays	NULL
F9	NULL
cells	NULL
were	NULL
seeded	NULL
onto	NULL
0.1	NULL
%	NULL
gelatin-treated	NULL
,	NULL
24-well	NULL
plates	NULL
(	NULL
5	NULL
x	NULL
10*	NULL
cells/well	NULL
)	NULL
1	NULL
day	NULL
before	NULL
transfection	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
LIPOFECTAMINE	NULL
``	NULL
Y	NULL
``	NULL
reagent	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
with	NULL
one	NULL
ug	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
driven	NULL
by	NULL
the	NULL
FeyRI	NULL
STAT	NULL
enhancer	NULL
(	NULL
GRR-STAT-Luc	NULL
,	NULL
ref	NULL
.	NULL

Nakajima	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
along	NULL
with	NULL
0.125	NULL
ug	NULL
of	NULL
cDNA	NULL
expression	NULL
vectors	NULL
encoding	NULL
wildtype	NULL
or	NULL
truncated	NULL
forms	NULL
of	NULL
c-Rel	NULL
or	NULL
RelA	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
(	NULL
Promega	NULL
)	NULL
40-48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Cell	NULL
proliferation	NULL
assays	NULL
Normal	NULL
or	NULL
HTLV-I-infected	NULL
human	NULL
T	NULL
cells	NULL
were	NULL
starved	NULL
for	NULL
30	NULL
h	NULL
in	NULL
RPMI	NULL
media	NULL
lacking	NULL
IL-2	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
aliquoted	NULL
into	NULL
a	NULL
96-well	NULL
plate	NULL
and	NULL
either	NULL
not	NULL
treated	NULL
or	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
plus	NULL
PHA	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

After	NULL
24-72	NULL
h	NULL
,	NULL
proliferation	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
determined	NULL
by	NULL
incubating	NULL
the	NULL
cells	NULL
with	NULL
a	NULL
non-radioactive	NULL
proliferation	NULL
assay	NULL
reagent	NULL
(	NULL
Promega	NULL
,	NULL
CellTiter	NULL
96	NULL
AQ	NULL
One	NULL
)	NULL
for	NULL
about	NULL
1	NULL
h	NULL
followed	NULL
by	NULL
measuring	NULL
the	NULL
absorbance	NULL
at	NULL
490nm	NULL
using	NULL
an	NULL
ELISA	NULL
plate	NULL
reader	NULL
.	NULL

Acknowledgements	NULL
We	NULL
thank	NULL
T	NULL
Hirano	NULL
for	NULL
GRR-luc	NULL
reporter	NULL
,	NULL
WC	NULL
Greene	NULL
for	NULL
c-Rel	NULL
cDNA	NULL
expression	NULL
vectors	NULL
.	NULL

EWH	NULL
is	NULL
supported	NULL
by	NULL
an	NULL
NIH	NULL
predoctoral	NULL
training	NULL
grant	NULL
5	NULL
T32	NULL
CA	NULL
6039-5	NULL
.	NULL

This	NULL
study	NULL
was	NULL
Supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
grant	NULL
1	NULL
ROL	NULL
CA68471-03	NULL
to	NULL
SCS	NULL
.	NULL

Hollsberg	NULL
P	NULL
,	NULL
Wucherpfennig	NULL
KW	NULL
,	NULL
Ausubel	NULL
AJ	NULL
,	NULL
Calvo	NULL
V	NULL
,	NULL
Bierer	NULL
BE	NULL
and	NULL
Hafler	NULL
DA	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
148	NULL
,	NULL
3256	NULL
3263	NULL
.	NULL

Thle	NULL
JN	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
84	NULL
,	NULL
331-334	NULL
.	NULL

Johnston	NULL
JA	NULL
,	NULL
Bacon	NULL
CM	NULL
,	NULL
Finbloom	NULL
DS	NULL
,	NULL
Rees	NULL
RC	NULL
,	NULL
Kaplan	NULL
D	NULL
,	NULL
Shibuya	NULL
K	NULL
,	NULL
Ortaldo	NULL
JR	NULL
,	NULL
Gupta	NULL
S	NULL
,	NULL
Chen	NULL
YQ	NULL
,	NULL
Giri	NULL
JD	NULL
and	NULL
O'Shea	NULL
JJ	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
,	NULL
8705-8709	NULL
.	NULL

Johnston	NULL
JA	NULL
,	NULL
Kawamura	NULL
M	NULL
,	NULL
Kirken	NULL
RA	NULL
,	NULL
Chen	NULL
YQ	NULL
,	NULL
Blake	NULL
TB	NULL
,	NULL
Shibuya	NULL
K	NULL
,	NULL
Ortaldo	NULL
JR	NULL
,	NULL
McVicar	NULL
DW	NULL
and	NULL
O'Shea	NULL
JJ	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
370	NULL
,	NULL
151-153	NULL
.	NULL

Kanno	NULL
T	NULL
,	NULL
Brown	NULL
K	NULL
,	NULL
Franzoso	NULL
G	NULL
and	NULL
Siebenlist	NULL
U	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
6443-6451	NULL
.	NULL

Kitajima	NULL
I	NULL
,	NULL
Shinohara	NULL
T	NULL
,	NULL
Bilakovies	NULL
J	NULL
,	NULL
Brown	NULL
DA	NULL
,	NULL
Xu	NULL
X	NULL
and	NULL
Nerenberg	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
258	NULL
,	NULL
1792-1795	NULL
.	NULL

Koeffler	NULL
HP	NULL
,	NULL
Chen	NULL
IS	NULL
and	NULL
Golde	NULL
DW	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
64	NULL
,	NULL
482-490	NULL
.	NULL

Kontgen	NULL
F	NULL
,	NULL
Grumont	NULL
RJ	NULL
,	NULL
Strasser	NULL
A	NULL
,	NULL
Metcalf	NULL
D	NULL
,	NULL
Li	NULL
R	NULL
,	NULL
Tarlinton	NULL
D	NULL
and	NULL
Gerondakis	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
9	NULL
,	NULL
1965-1977	NULL
.	NULL

Lacoste	NULL
J	NULL
,	NULL
Petropoulos	NULL
L	NULL
,	NULL
PÃ©pin	NULL
N	NULL
and	NULL
Hiscott	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
69	NULL
,	NULL
564-569	NULL
.	NULL

Li	NULL
C-C	NULL
,	NULL
Ruscetti	NULL
FW	NULL
,	NULL
Rice	NULL
NR	NULL
,	NULL
Chen	NULL
E	NULL
,	NULL
Yang	NULL
N-S	NULL
,	NULL
Mikovits	NULL
J	NULL
and	NULL
Longo	NULL
DL	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
67	NULL
,	NULL
4205-4213	NULL
.	NULL

Lin	NULL
J-X	NULL
,	NULL
Migone	NULL
T-S	NULL
,	NULL
Tsang	NULL
M	NULL
,	NULL
Friedmann	NULL
M	NULL
,	NULL
Weatherbee	NULL
JA	NULL
,	NULL
Zhou	NULL
L	NULL
,	NULL
Yamauchi	NULL
A	NULL
,	NULL
Bloom	NULL
ET	NULL
,	NULL
Mietz	NULL
J	NULL
,	NULL
John	NULL
S	NULL
and	NULL
Leonard	NULL
WJ	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
2	NULL
,	NULL
331-339	NULL
.	NULL

McKinsey	NULL
TA	NULL
,	NULL
Brockman	NULL
JA	NULL
,	NULL
Scherer	NULL
DC	NULL
,	NULL
Al-Murrani	NULL
SW	NULL
,	NULL
Green	NULL
PL	NULL
and	NULL
Ballard	NULL
WB	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
2083-2090	NULL
.	NULL

Merl	NULL
S	NULL
,	NULL
Kloster	NULL
B	NULL
,	NULL
Moore	NULL
J	NULL
,	NULL
Hubbell	NULL
C	NULL
,	NULL
Tomar	NULL
R	NULL
,	NULL
Davey	NULL
F	NULL
,	NULL
Kalinowski	NULL
D	NULL
,	NULL
Planas	NULL
A	NULL
,	NULL
Ehrlich	NULL
G	NULL
and	NULL
Clark	NULL
D.	NULL
(	NULL
1984	NULL
)	NULL
.	NULL

Blood	NULL
,	NULL
64	NULL
,	NULL
967-974	NULL
.	NULL

Migone	NULL
T-S	NULL
,	NULL
Lin	NULL
J-X	NULL
,	NULL
Cereseto	NULL
A	NULL
,	NULL
Mulloy	NULL
JC	NULL
,	NULL
O'Shea	NULL
JJ	NULL
,	NULL
Franchini	NULL
G	NULL
and	NULL
Leonard	NULL
WJ	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
269	NULL
,	NULL
79-81	NULL
.	NULL

Miyoshi	NULL
I	NULL
,	NULL
Kubonishi	NULL
I	NULL
,	NULL
Yoshimoto	NULL
S	NULL
and	NULL
Shiraishi	NULL
Y	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
.	NULL

Gann	NULL
,	NULL
72	NULL
,	NULL
978-981	NULL
.	NULL

Mui	NULL
AL-F	NULL
,	NULL
Wakao	NULL
H	NULL
,	NULL
O'Farrell	NULL
A-M	NULL
,	NULL
Harada	NULL
N	NULL
and	NULL
Miyajima	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
6	NULL
,	NULL
1166-1175	NULL
.	NULL

Mulloy	NULL
JC	NULL
,	NULL
Migone	NULL
T-S	NULL
,	NULL
Ross	NULL
TM	NULL
,	NULL
Ton	NULL
N	NULL
,	NULL
Green	NULL
PL	NULL
,	NULL
Leonard	NULL
WJ	NULL
and	NULL
Franchini	NULL
G.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
72	NULL
,	NULL
4408	NULL
4412	NULL
.	NULL

Nakajima	NULL
K	NULL
,	NULL
Yamanaka	NULL
Y	NULL
,	NULL
Nakae	NULL
K	NULL
,	NULL
Kojima	NULL
H	NULL
,	NULL
Ichiba	NULL
M	NULL
,	NULL
Kiuchi	NULL
N	NULL
,	NULL
Kitaoka	NULL
T	NULL
,	NULL
Fukada	NULL
T	NULL
,	NULL
Hibi	NULL
M	NULL
and	NULL
Hirano	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
15	NULL
,	NULL
3651-3658	NULL
.	NULL

O'Shea	NULL
JJ	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
7	NULL
,	NULL
1-11	NULL
.	NULL

Persaud	NULL
D	NULL
,	NULL
Munoz	NULL
JL	NULL
,	NULL
Tarsis	NULL
SL	NULL
,	NULL
Parks	NULL
ES	NULL
and	NULL
Parks	NULL
WP	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
69	NULL
,	NULL
6297-6303	NULL
.	NULL

Poiesz	NULL
BF	NULL
,	NULL
Ruscetti	NULL
FW	NULL
,	NULL
Gazdar	NULL
AF	NULL
,	NULL
Bunn	NULL
PA	NULL
,	NULL
Minna	NULL
JD	NULL
and	NULL
Gallo	NULL
RC	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
77	NULL
,	NULL
7415-7419	NULL
.	NULL

Ressler	NULL
S	NULL
,	NULL
Connor	NULL
LM	NULL
and	NULL
Marriott	NULL
SJ	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

FEBS	NULL
Microbiol	NULL
.	NULL

Lett	NULL
.	NULL

,	NULL
140	NULL
,	NULL
99-109	NULL
.	NULL

Salahuddin	NULL
SZ	NULL
,	NULL
Markham	NULL
P	NULL
,	NULL
Wong-Staal	NULL
F	NULL
,	NULL
Franchini	NULL
G	NULL
,	NULL
Kalyanaraman	NULL
VS	NULL
and	NULL
Gallo	NULL
RC	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
.	NULL

Virology	NULL
,	NULL
129	NULL
,	NULL
51-64	NULL
.	NULL

Functional	NULL
binding	NULL
of	NULL
c-Rel	NULL
to	NULL
STATS	NULL
target	NULL
sequences	NULL
SC	NULL
Sun	NULL
et	NULL
al	NULL
Schindler	NULL
C	NULL
and	NULL
Darnell	NULL
JE	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
64	NULL
,	NULL
621-651	NULL
.	NULL

Schreiber	NULL
E	NULL
,	NULL
Matthias	NULL
P	NULL
,	NULL
Muller	NULL
MM	NULL
and	NULL
Schaffner	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

Nucl	NULL
.	NULL

Acids	NULL
Res	NULL
.	NULL

,	NULL
17	NULL
,	NULL
6419	NULL
.	NULL

Schwartz	NULL
RH	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
248	NULL
,	NULL
1349-1356	NULL
.	NULL

Shen	NULL
C-H	NULL
and	NULL
Stavnezer	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
18	NULL
,	NULL
3395-3404	NULL
.	NULL

Siebenlist	NULL
U	NULL
,	NULL
Franzoso	NULL
G	NULL
and	NULL
Brown	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
10	NULL
,	NULL
405-455	NULL
.	NULL

Smith	NULL
MR	NULL
and	NULL
Greene	NULL
WC	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

J.	NULL
C/in	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
87	NULL
,	NULL
761	NULL
766	NULL
.	NULL

Sodroski	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1114	NULL
,	NULL
19-29	NULL
.	NULL

Stancovski	NULL
I	NULL
and	NULL
Baltimore	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
91	NULL
,	NULL
299-302	NULL
.	NULL

Sun	NULL
S-C	NULL
,	NULL
Elwood	NULL
J	NULL
,	NULL
BÃ©raud	NULL
C	NULL
and	NULL
Greene	NULL
WC	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Mol	NULL
,	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
7377-7384	NULL
.	NULL

Takemoto	NULL
S	NULL
,	NULL
Mulloy	NULL
JC	NULL
,	NULL
Cereseto	NULL
A	NULL
,	NULL
Migone	NULL
TS	NULL
,	NULL
Patel	NULL
BK	NULL
,	NULL
Matsuoka	NULL
M	NULL
,	NULL
Yamaguchi	NULL
K	NULL
,	NULL
Takatsuki	NULL
K	NULL
,	NULL
Kamihira	NULL
S	NULL
,	NULL
White	NULL
JD	NULL
,	NULL
Leonard	NULL
WJ	NULL
,	NULL
Waldmann	NULL
T	NULL
and	NULL
Franchini	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
94	NULL
,	NULL
13897-13902	NULL
.	NULL

Uchiyama	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
15-37	NULL
.	NULL

Witthuhn	NULL
BA	NULL
,	NULL
Silvennoinen	NULL
O	NULL
,	NULL
Miura	NULL
O	NULL
,	NULL
Lai	NULL
KS	NULL
,	NULL
Cwik	NULL
C	NULL
,	NULL
Liu	NULL
ET	NULL
and	NULL
Ihle	NULL
JN	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
370	NULL
,	NULL
153-157	NULL
.	NULL

Xu	NULL
X	NULL
,	NULL
Kang	NULL
SH	NULL
,	NULL
Heidenreich	NULL
O	NULL
,	NULL
Okerholm	NULL
N	NULL
,	NULL
O'Shea	NULL
JJ	NULL
and	NULL
Nerenberg	NULL
MI	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
96	NULL
,	NULL
1548-1555	NULL
.	NULL

Yamaoka	NULL
S	NULL
,	NULL
Inoue	NULL
H	NULL
,	NULL
Sakurai	NULL
M	NULL
,	NULL
Sugiyama	NULL
T	NULL
,	NULL
Hazama	NULL
M	NULL
,	NULL
Yamada	NULL
T	NULL
and	NULL
Hatanaka	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
15	NULL
,	NULL
873-	NULL
887	NULL
.	NULL

Yoshida	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

Clin	NULL
.	NULL

Oncol	NULL
.	NULL

,	NULL
121	NULL
,	NULL
521-528	NULL
.	NULL

Yoshida	NULL
M	NULL
,	NULL
Miyoshi	NULL
I	NULL
and	NULL
Hinuma	NULL
Y	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
79	NULL
,	NULL
2031-2035	NULL
.	NULL

1409	NULL

